All Stories

  1. Environmental Stressors and Cardiovascular Health: Acting Locally for Global Impact in a Changing World: A Statement of the European Society of Cardiology, the American College of Cardiology, the American Heart Association, and the World Heart Federation
  2. Environmental stressors and cardiovascular health: acting locally for global impact in a changing world
  3. Angiotensin-Converting Enzyme (ACE) Inhibitors and Statins Mitigate Negative Cardiovascular and Pulmonary Effects of Particulate Matter in a Mouse Exposure Model
  4. From noise to heart disease: European Environment Agency sounds the alarm for Europe 2025
  5. Environmental Stressors and Cardiovascular Health: Acting Locally for Global Impact in a Changing World
  6. Nicotine and the cardiovascular system: unmasking a global public health threat
  7. Prenatal Pollution and Programmed Hypertension: Nrf-2/NLRP3 at the Crossroads
  8. Assessing Vascular Tone and Fluid Balance in Septic and Cardiogenic Shock: A Feasibility Study on Skin Water Loss as a Diagnostic Tool
  9. Imaging Findings Associated With Socioenvironmental Exposures Inform Mechanisms of Cardiovascular Disease
  10. A comprehensive review/expert statement on environmental risk factors of cardiovascular disease
  11. Championing environmental sustainability in cardiology: the ESC Task Force’s vision for a healthier future. A Task Force with a mission
  12. The links between soil and water pollution and cardiovascular disease
  13. Environmental Hypertensionology and the Mosaic Theory of Hypertension
  14. Transportation noise and the cardiometabolic risk
  15. Interventions by Cardiovascular Drugs Against Aircraft Noise-Induced Cardiovascular Oxidative Stress and Damage
  16. Auswirkungen von Lärm und Luftverschmutzung auf das Herz-Kreislauf-System und auf chronische Erkrankungen
  17. How quitting, switching to e-cigarettes, or sticking to smoking shapes cardiovascular outcomes after percutaneous coronary intervention
  18. “Split Impact: Road Traffic Directly Strains the Heart, Railway Noise Fuels Metabolic Risk—The Need for Tailored Noise Control”
  19. Challenges posed by climate hazards to cardiovascular health and cardiac intensive care: implications for mitigation and adaptation
  20. Soil and water pollution and cardiovascular disease
  21. Effects of Short-Term Gluten-Free Diet on Cardiovascular Biomarkers and Quality of Life in Healthy Individuals: A Prospective Interventional Study
  22. Pathomechanistic Synergy Between Particulate Matter and Traffic Noise-Induced Cardiovascular Damage and the Classical Risk Factor Hypertension
  23. Incidence and impact of venous thromboembolism in hospitalized patients with acute pancreatitis
  24. Quantifying Hemodynamic Cardiac Stress and Cardiomyocyte Injury in Normotensive and Hypertensive Acute Heart Failure
  25. Transportation Noise Pollution and Cardiovascular Health
  26. Injection Site Matters: A Comparative Analysis of Transpulmonary Thermodilution via Simultaneous Femoral and Jugular Indicator Injections under Veno-Venous Extracorporeal Membrane Oxygenation Therapy
  27. The Urban Environment and Cardiometabolic Health
  28. Drivers and recent trends of hospitalisation costs related to acute pulmonary embolism
  29. Crosstalk between Oxidative Stress and Inflammation Caused by Noise and Air Pollution—Implications for Neurodegenerative Diseases
  30. Breathing danger: linking air pollution to cardiovascular disease and increased risk of abdominal aortic aneurysm
  31. Coding Hypertension by Nicotine: Unraveling the Sex-Specific Role Of m6A Demethylase for NOX2 RNA-Protein Connection
  32. Air pollution deaths attributable to fossil fuels: observational and modelling study
  33. Clearing the air, saving lives: understanding air pollution’s impact on out-of-hospital cardiac arrest
  34. Autoantibodies against the chemokine receptor 3 predict cardiovascular risk
  35. Air Pollution and Neuropsychiatric Disease
  36. Noise Pollution and Neuropsychiatric Disease
  37. Oxidative Stress and Inflammation Contribute to Traffic Noise-Induced Vascular and Cerebral Dysfunction via Uncoupling of Nitric Oxide Synthases
  38. The Exposome Concept
  39. Late-Onset Prosthetic Endocarditis with Paraaortic Abscess Caused by Cutibacterium acnes
  40. Development and Phenotype of Heart Failure in Long‐Term Survivors of Childhood Cancer: The CVSS Study
  41. Cumulative social disadvantage and cardiovascular disease burden and mortality
  42. Circulating Soluble EPCR Levels Are Reduced in Patients with Ischemic Peripheral Artery Disease and Associated with Markers of Endothelial and Vascular Function
  43. Diabetes Mellitus and Its Association with Adverse In-Hospital Outcomes in Patients with COVID-19—A Nationwide Study
  44. The contribution of the exposome to the burden of cardiovascular disease
  45. Environmental Stressors and the Endothelium
  46. E-cigarette effects on vascular function in animals and humans
  47. Noise and Air Pollution as Risk Factors for Hypertension: Part II—Pathophysiologic Insight
  48. Noise and Air Pollution as Risk Factors for Hypertension: Part I—Epidemiology
  49. Vascular Redox Signaling, Endothelial Nitric Oxide Synthase Uncoupling, and Endothelial Dysfunction in the Setting of Transportation Noise Exposure or Chronic Treatment with Organic Nitrates
  50. Noise, Air, and Heavy Metal Pollution as Risk Factors for Endothelial Dysfunction
  51. The emergence of the air pollutant ozone as a significant cardiovascular killer?
  52. Early Detection Is the Best Prevention—Characterization of Oxidative Stress in Diabetes Mellitus and Its Consequences on the Cardiovascular System
  53. CRB-65 for Risk Stratification and Prediction of Prognosis in Pulmonary Embolism
  54. Extracorporeal CPR in Out-of-Hospital Cardiac Arrest — Still on Life Support?
  55. Are e-cigarettes dangerous or do they boost our health: no END(S) of the discussion in sight
  56. Case Fatality of Hospitalized Patients with COVID-19 Infection Suffering from Acute Respiratory Distress Syndrome in Germany
  57. Temporal Trends in Patients with Peripheral Artery Disease Influenced by COVID-19 Pandemic
  58. Acute Exposure to Simulated Nocturnal Train Noise Leads to Impaired Sleep Quality and Endothelial Dysfunction in Young Healthy Men and Women: A Sex-Specific Analysis
  59. Arginase-1 Deletion in Erythrocytes Promotes Vascular Calcification via Enhanced GSNOR (S-Nitrosoglutathione Reductase) Expression and NO Signaling in Smooth Muscle Cells
  60. Those declared dead live longer
  61. Case-Fatality and Temporal Trends in Patients with Psoriasis and End-Stage Renal Disease
  62. Soil and water pollution and human health: what should cardiologists worry about?
  63. Intramyocardial Inflammation after COVID-19 Vaccination: An Endomyocardial Biopsy-Proven Case Series
  64. Measurement of Tetrahydrobiopterin in Animal Tissue Samples by HPLC with Electrochemical Detection—Protocol Optimization and Pitfalls
  65. EPCR−PAR1 biased signaling regulates perfusion recovery and neovascularization in peripheral ischemia
  66. The manual of cardiovascular medicine, Oxford University Press 2022: just a pocket guide but ‘all inclusive’
  67. Atherosclerosis and Its Impact on the Outcomes of Patients with Deep Venous Thrombosis
  68. Mechanistic Insights into Inorganic Nitrite-Mediated Vasodilation of Isolated Aortic Rings under Oxidative/Hypertensive Conditions and S-Nitros(yl)ation of Proteins in Germ-Free Mice
  69. Short and Concise Peer-to-Peer Teaching—Example of a Successful Antibiotic Stewardship Intervention to Increase Iv to Po Conversion
  70. Trends and Risk Factors of In-Hospital Mortality of Patients with COVID-19 in Germany: Results of a Large Nationwide Inpatient Sample
  71. Endothelial dysfunction: basis for many local and systemic conditions
  72. Influence of Peripheral Transluminal Angioplasty Alongside Exercise Training on Oxidative Stress and Inflammation in Patients with Peripheral Arterial Disease
  73. Lack of Endothelial α1AMPK Reverses the Vascular Protective Effects of Exercise by Causing eNOS Uncoupling
  74. Reduced Aircraft Noise Pollution During COVID-19 Lockdown Is Beneficial to Public Cardiovascular Health: a Perspective on the Reduction of Transportation-Associated Pollution
  75. Sleepless in Seattle: Sleep Deprivation and Fragmentation Impair Endothelial Function and Fibrinolysis in Hypertension
  76. Das Exposom charakterisiert die Auswirkungen unserer Umwelt auf Stoffwechsel und Gesundheit
  77. Gesundheitsrisiko Mobilfunkstrahlung? Was ändert sich mit 5G?
  78. Herzgesunde Städte – die Gene laden das Gewehr, die Umwelt zieht den Abzug
  79. Lebensstil und kardiovaskuläre Gesundheit – wie schädlich sind E-Zigaretten und Shisha-Rauchen?
  80. Long-Term Exposure to Transportation Noise and Risk for Type 2 Diabetes in a Nationwide Cohort Study from Denmark
  81. Luftverschmutzung und Herz-Kreislauf-Erkrankungen
  82. Lärm und Herz-Kreislauf-Erkrankungen
  83. Nachtlärminduzierte Schlafstörungen und Herz-Kreislauf-Risiko
  84. Risk Factors for Pulmonary Embolism in Patients with Paralysis and Deep Venous Thrombosis
  85. Effectiveness of a Real-Time X-ray Dosimetry Monitor in Reducing Radiation Exposure in Coronary Procedures: The ESPRESSO-Raysafe Randomized Trial
  86. B Lymphocyte-Deficiency in Mice Causes Vascular Dysfunction by Inducing Neutrophilia
  87. Physical Activity in Polluted Air—Net Benefit or Harm to Cardiovascular Health? A Comprehensive Review
  88. Association of Birth Weight with Central and Peripheral Corneal Thickness in Adulthood—Results from the Population-Based German Gutenberg Health Study
  89. Diabetes Mellitus and Its Impact on Patient-Profile and In-Hospital Outcomes in Peripheral Artery Disease
  90. Disturbed Lipid Metabolism in Diabetic Patients with Manifest Coronary Artery Disease Is Associated with Enhanced Inflammation
  91. Environmental risk factors and cardiovascular diseases: a comprehensive expert review
  92. Disturbed Glucose Metabolism and Left Ventricular Geometry in the General Population
  93. GLP-1 Analog Liraglutide Improves Vascular Function in Polymicrobial Sepsis by Reduction of Oxidative Stress and Inflammation
  94. Long-Term Outcome with New Generation Prostheses in Patients Undergoing Transcatheter Aortic Valve Replacement
  95. A pathophysiological compass to personalize antianginal drug treatment
  96. Non‐bacterial thrombotic endocarditis in a patient with pancreatic carcinoma
  97. Smoking and Neuropsychiatric Disease—Associations and Underlying Mechanisms
  98. Takotsubo Syndrome: Impact of endothelial dysfunction and oxidative stress
  99. Effects of Dietary Protein Intake on Cutaneous and Systemic Inflammation in Mice with Acute Experimental Psoriasis
  100. Ethnic comparison in takotsubo syndrome: novel insights from the International Takotsubo Registry
  101. Heart healthy cities: genetics loads the gun but the environment pulls the trigger
  102. Role of angiopoietin-2 in venous thrombus resolution and chronic thromboembolic disease
  103. Distribution of estimated glomerular filtration rate and determinants of its age dependent loss in a German population-based study
  104. Protein expression profiling suggests relevance of noncanonical pathways in isolated pulmonary embolism
  105. Running in polluted air is a two-edged sword — physical exercise in low air pollution areas is cardioprotective but detrimental for the heart in high air pollution areas
  106. Detection of extracellular superoxide in isolated human immune cells and in an animal model of arterial hypertension using hydropropidine probe and HPLC analysis
  107. Noise-Induced Vascular Dysfunction, Oxidative Stress, and Inflammation Are Improved by Pharmacological Modulation of the NRF2/HO-1 Axis
  108. Transportation noise pollution and cardiovascular disease
  109. ACE Inhibition Modulates Myeloid Hematopoiesis after Acute Myocardial Infarction and Reduces Cardiac and Vascular Inflammation in Ischemic Heart Failure
  110. Accelerated Aging and Age-Related Diseases (CVD and Neurological) due to Air Pollution and Traffic Noise Exposure
  111. The Bioengineered Combo Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Coronary Stent in Patients with Chronic Total Occlusion Evaluated by Clinical Outcome and Optical Coherence Tomography Imaging Analysis
  112. Ambient Air Pollution and Atherosclerosis
  113. In-hospital outcomes of catheter-directed thrombolysis in patients with pulmonary embolism
  114. CD40/CD40L and Related Signaling Pathways in Cardiovascular Health and Disease—The Pros and Cons for Cardioprotection
  115. Reduction of environmental pollutants for prevention of cardiovascular disease: it’s time to act
  116. Regional and global contributions of air pollution to risk of death from COVID-19
  117. Environmental Factors Such as Noise and Air Pollution and Vascular Disease
  118. Safety of transradial and transfemoral left ventricular compared with transfemoral right ventricular endomyocardial biopsy
  119. Psoriasis and Its Impact on In-Hospital Outcome in Patients Hospitalized with Acute Kidney Injury
  120. Impact of Psoriasis on Mortality Rate and Outcome in Myocardial Infarction
  121. Association of transcatheter direct mitral annuloplasty with acute anatomic, haemodynamic, and clinical outcomes in severe mitral valve regurgitation
  122. Recalled parental rearing behavior in adult women and men with depressive and anxiety symptoms: Findings from a community study
  123. Relation between Tissue Factor Pathway Inhibitor Activity and Cardiovascular Risk Factors and Diseases in a Large Population Sample
  124. Impact of concomitant deep or superficial venous thrombosis of the legs on survival of patients with pulmonary embolism
  125. Could E-cigarette vaping contribute to heart disease?
  126. Peripapillary Retinal Nerve Fiber Layer Profile in Relation to Refractive Error and Axial Length: Results From the Gutenberg Health Study
  127. T1 and T2 mapping to detect chronic inflammation in cardiac magnetic resonance imaging in heart failure with reduced ejection fraction
  128. Kriterien der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung für „Chest Pain Units“
  129. Feasibility of a MPR‐based 3DTEE guidance protocol for transcatheter direct mitral valve annuloplasty
  130. Auswirkungen von Umweltrisikofaktoren wie Lärm und Luftverschmutzung auf die psychische Gesundheit: Was wissen wir?
  131. Fetal programming effects of pentaerythritol tetranitrate in a rat model of superimposed preeclampsia
  132. Long-term residential road traffic noise and mortality in a Danish cohort
  133. Prevalence of Strabismus and Its Impact on Vision-Related Quality of Life
  134. Symptoms of depersonalization/derealization are independent risk factors for the development or persistence of psychological distress in the general population: Results from the Gutenberg health study
  135. Sex-dependent associations of low birth weight and suicidal ideation in adulthood: a community-based cohort study
  136. Neochord anterior leaflet treatment to facilitate transcatheter mitral valve replacement with 3D real-time echocardiography
  137. EkoSonic® endovascular system and other catheter-directed treatment reperfusion strategies for acute pulmonary embolism: overview of efficacy and safety outcomes
  138. Results from the Population-Based Gutenberg Health Study Revealing Four Altered Autoantibodies in Retinal Vein Occlusion Patients
  139. The association of chronic anxiousness with cardiovascular disease and mortality in the community: results from the Gutenberg Health Study
  140. Transcatheter left ventricular reshape of apical ischaemic aneurysm achieves left ventricular remodelling, improves wall motion, causes papillary muscle approximation, and a reduction of secondary MVR
  141. The association between recalled parental rearing behavior and depressiveness: a comparison between 1st immigrants and non-immigrants in the population-based Gutenberg Health Study
  142. Association of Birth Weight with Peripapillary Retinal Nerve Fiber Layer Thickness in Adulthood—Results from a Population-Based Study
  143. Exacerbation of adverse cardiovascular effects of aircraft noise in an animal model of arterial hypertension
  144. Isolated Pulmonary Embolism Is Associated With a High Risk of Arterial Thrombotic Disease
  145. Novel Concept for the Regulation of eNOS (Endothelial Nitric Oxide Synthase) Activity
  146. Oxidative stress and inflammation contribute to traffic noise-induced vascular and cerebral dysfunction via uncoupling of nitric oxide synthases
  147. Temporal trends and predictors of inhospital death in patients hospitalised for heart failure in Germany
  148. Inappropriate evaluation of methodology and biases by P. Morfeld and T.C. Erren
  149. Prevalence of pterygium and identification of associated factors in a German population – results from the Gutenberg Health Study
  150. Fatality rates and use of systemic thrombolysis in pregnant women with pulmonary embolism
  151. Evidence of SARS-CoV-2 mRNA in endomyocardial biopsies of patients with clinically suspected myocarditis tested negative for COVID-19 in nasopharyngeal swab
  152. Ambient Air Pollution Increases the Risk of Cerebrovascular and Neuropsychiatric Disorders through Induction of Inflammation and Oxidative Stress
  153. The AMP-Activated Protein Kinase Plays a Role in Antioxidant Defense and Regulation of Vascular Inflammation
  154. Cardiovascular health outcomes of mobbing at work: results of the population-based, five-year follow-up of the Gutenberg health study
  155. Interplay of the red blood cell and vascular endothelial nitric oxide synthase system to combat cardiac complications of anemia
  156. Predictors of short‐ and long‐term outcomes of patients undergoing transcatheter mitral valve edge‐to‐edge repair
  157. Frequency of cataract surgery and its impact on visual function—results from the German Gutenberg Health Study
  158. Transcatheter indirect mitral annuloplasty induces annular and left atrial remodelling in secondary mitral regurgitation
  159. Corrigendum
  160. Randomised, non-inferiority, controlled procedural outcomes TrIal comParing reverse T And Protrusion versus double-kissing and crush stenting: protocol of the TIP TAP I randomised trial
  161. Venous thromboembolism in patients hospitalized for hip joint replacement surgery
  162. Capacity changes in German certified chest pain units during COVID-19 outbreak response
  163. Rationale, design and baseline characteristics of the MyoVasc study: A prospective cohort study investigating development and progression of heart failure
  164. Regulation of Vascular Function and Inflammation via Cross Talk of Reactive Oxygen and Nitrogen Species from Mitochondria or NADPH Oxidase—Implications for Diabetes Progression
  165. Development of an Analytical Assay for Electrochemical Detection and Quantification of Protein-Bound 3-Nitrotyrosine in Biological Samples and Comparison with Classical, Antibody-Based Methods
  166. Coronary stent thrombosis—predictors and prevention
  167. Kansas City Cardiomyopathy Quality Score Indicates Sustained Health Status Improvement in Patients After TMVr
  168. Road Traffic Noise Exposure and Filled Prescriptions for Antihypertensive Medication: A Danish Cohort Study
  169. Bevölkerungsbezogene psychische Gesundheit als Schlüsselfaktor im Umgang mit COVID-19
  170. Apple Watch detecting coronary ischaemia during chest pain episodes or an apple a day may keep myocardial infarction away
  171. Renal Effects of Fetal Reprogramming With Pentaerythritol Tetranitrate in Spontaneously Hypertensive Rats
  172. Midregional pro atrial natriuretic peptide: a novel important biomarker for noise annoyance-induced cardiovascular morbidity and mortality?
  173. No evidence for an association of plasma homocysteine levels and refractive error – Results from the population-based Gutenberg Health Study (GHS)
  174. Corrigendum
  175. Adverse Cardiovascular Effects of Traffic Noise with a Focus on Nighttime Noise and the New WHO Noise Guidelines
  176. Environmental aircraft noise aggravates oxidative DNA damage, granulocyte oxidative burst and nitrate resistance in Ogg1–/– mice
  177. Resting and recruitable endothelial function – Evidence of two distinct circadian patterns
  178. Sex-specific and age-related seasonal variations regarding incidence and in-hospital mortality of pulmonary embolism in Germany
  179. Age-Related Variations in Takotsubo Syndrome
  180. German chest pain unit registry: data review after the first decade of certification
  181. Acrolein, e-cigarettes, and pulmonary and vascular damage
  182. Iron deficiency is a common disorder in general population and independently predicts all-cause mortality: results from the Gutenberg Health Study
  183. Five Years Outcomes and Predictors of Events in a Single-Center Cohort of Patients Treated with Bioresorbable Coronary Vascular Scaffolds
  184. Prevalence and new onset of depression and anxiety among participants with AMD in a European cohort
  185. Loss of life expectancy from air pollution compared to other risk factors: a worldwide perspective
  186. Bioresorbable vascular scaffolds versus everolimus-eluting metallic stents in patients with ST-segment elevation myocardial infarction: 5-year results of the BVS-EXAMINATION study
  187. Impact of atrial fibrillation/flutter on the in-hospital mortality of ischemic stroke patients
  188. Trends in mortality related to pulmonary embolism in the European Region, 2000–15: analysis of vital registration data from the WHO Mortality Database
  189. Specialized Management of Oral Anticoagulation Therapy Improves Outcome in Patients with Chronic Renal Insufficiency
  190. Air pollution, the underestimated cardiovascular risk factor
  191. Long-term cardiovascular risk of e-cigarettes
  192. Frequency of stressful life events and associations with mental health and general subjective health in the general population
  193. Noise annoyance predicts symptoms of depression, anxiety and sleep disturbance 5 years later. Findings from the Gutenberg Health Study
  194. Influence of mental stress and environmental toxins on circadian clocks: Implications for redox regulation of the heart and cardioprotection
  195. Impact of aspirin on takotsubo syndrome: a propensity score‐based analysis of the InterTAK Registry
  196. Quality benchmarks for chest pain units and stroke units in Germany
  197. Diagnosis and risk stratification of chest pain patients in the emergency department: focus on acute coronary syndromes. A position paper of the Acute Cardiovascular Care Association
  198. Activated Endothelial TGFβ1 Signaling Promotes Venous Thrombus Nonresolution in Mice Via Endothelin-1
  199. QFR Predicts the Incidence of Long-Term Adverse Events in Patients with Suspected CAD: Feasibility and Reproducibility of the Method
  200. Predictors for Target Vessel Failure after Recanalization of Chronic Total Occlusions in Patients Undergoing Surveillance Coronary Angiography
  201. Effects of clopidogrel vs. prasugrel vs. ticagrelor on endothelial function, inflammatory parameters, and platelet function in patients with acute coronary syndrome undergoing coronary artery stenting: a randomized, blinded, parallel study
  202. Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome
  203. Endothelial GLP-1 (Glucagon-Like Peptide-1) Receptor Mediates Cardiovascular Protection by Liraglutide In Mice With Experimental Arterial Hypertension
  204. Gender Differences in Patients Admitted to a Certified German Chest Pain Unit: Results from the German Chest Pain Unit Registry
  205. Schirmer test results: are they associated with topical or systemic medication?
  206. Traffic-related environmental risk factors and their impact on oxidative stress and cardiovascular health
  207. Intraventricular Thrombus Formation and Embolism in Takotsubo Syndrome
  208. Age-Dependent and -Independent Effects of Perivascular Adipose Tissue and Its Paracrine Activities during Neointima Formation
  209. The sixth sense is involved in noise-induced stress responses and vascular inflammation: evidence for heightened amygdalar activity in response to transport noise in man
  210. Effect of a Strategy of Comprehensive Vasodilation vs Usual Care on Mortality and Heart Failure Rehospitalization Among Patients With Acute Heart Failure
  211. Thrombin generation in cardiovascular disease and mortality - results from the Gutenberg Health Study
  212. KCND3 potassium channel gene variant confers susceptibility to electrocardiographic early repolarization pattern
  213. Association between medicated obstructive pulmonary disease, depression and subjective health: results from the population-based Gutenberg Health Study
  214. Course of depressive symptoms in men and women: differential effects of social, psychological, behavioral and somatic predictors
  215. Low Birth Weight Is Linked to Age-Related Macular Degeneration: Results From the Population-Based Gutenberg Health Study (GHS)
  216. Short-term e-cigarette vapour exposure causes vascular oxidative stress and dysfunction: evidence for a close connection to brain damage and a key role of the phagocytic NADPH oxidase (NOX-2)
  217. Environmental Noise-Induced Effects on Stress Hormones, Oxidative Stress, and Vascular Dysfunction: Key Factors in the Relationship between Cerebrocardiovascular and Psychological Disorders
  218. Clinical Predictors and Prognostic Impact of Recovery of Wall Motion Abnormalities in Takotsubo Syndrome: Results From the International Takotsubo Registry
  219. Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes
  220. Characteristics and pathologies of the vitreo‐macular interface—results from the Gutenberg Health Study
  221. Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial
  222. Intact Visuospatial Cognition in Amblyopia: Results From the Gutenberg Health Study
  223. The anti-cancer drug doxorubicin induces substantial epigenetic changes in cultured cardiomyocytes
  224. Transcatheter Mitral Valve Repair: Single Stage Combo Approach
  225. Acute exposure to nocturnal train noise induces endothelial dysfunction and pro-thromboinflammatory changes of the plasma proteome in healthy subjects
  226. Comparison of Mitochondrial Superoxide Detection Ex Vivo/In Vivo by mitoSOX HPLC Method with Classical Assays in Three Different Animal Models of Oxidative Stress
  227. The air pollution constituent particulate matter (PM2.5) destabilizes coronary artery plaques
  228. Endothelial Function Assessed by Digital Volume Plethysmography Predicts the Development and Progression of Type 2 Diabetes Mellitus
  229. Luftverschmutzung und Herz-Kreislauf-System
  230. Advanced Protocol for Three-Dimensional Transesophageal Echocardiography Guidance Implementing Real-Time Multiplanar Reconstruction for Transcatheter Mitral Valve Repair by Direct Annuloplasty
  231. Obesity paradox in peripheral artery disease
  232. Survival Benefit of Obese Patients With Pulmonary Embolism
  233. Estimated stroke risk, yield, and number needed to screen for atrial fibrillation detected through single time screening: a multicountry patient-level meta-analysis of 141,220 screened individuals
  234. The “exposome” concept – how environmental risk factors influence cardiovascular health
  235. The harms to health caused by aviation noise require urgent action
  236. A prospective cohort study to identify and evaluate endotypes of venous thromboembolism: Rationale and design of the Genotyping and Molecular Phenotyping in Venous ThromboEmbolism project (GMP-VTE)
  237. Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome
  238. Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery
  239. Linking cancer and mental health in men and women in a representative community sample
  240. Telmisartan Lowers Elevated Blood Pressure in Psoriatic Mice without Attenuating Vascular Dysfunction and Inflammation
  241. Reply to ‘Relationship between stent fracture and thrombosis’
  242. Prediction of short‐ and long‐term mortality in takotsubo syndrome: the InterTAK Prognostic Score
  243. Clinical Features and Outcomes of Patients With Malignancy and Takotsubo Syndrome: Observations From the International Takotsubo Registry
  244. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
  245. T Cell-Derived IL-17A Induces Vascular Dysfunction via Perivascular Fibrosis Formation and Dysregulation of ⋅NO/cGMP Signaling
  246. Effect of Alirocumab on Mortality After Acute Coronary Syndromes
  247. Increased Lymphangiogenesis and Lymphangiogenic Growth Factor Expression in Perivascular Adipose Tissue of Patients with Coronary Artery Disease
  248. Educating Children for a Healthy Lifestyle
  249. Effectiveness of additional X-ray protection devices in reducing Scattered radiation in radial interventions: protocol of the ESPRESSO randomised trial
  250. RENIN, ALDOSTERONE, THE ALDOSTERONE-TO-RENIN RATIO AND INCIDENT ARTERIAL HYPERTENSION AMONG NORMOTENSIVE SUBJECTS FROM THE POPULATION
  251. Sex-specific differences regarding seasonal variations of incidence and mortality in patients with myocardial infarction in Germany
  252. Comparison between treatment of “established” versus complex “off-label” coronary lesions with Absorb® bioresorbable scaffold implantation: results from the GABI-R® registry
  253. Application of High-Sensitivity Troponin in Suspected Myocardial Infarction
  254. Up in the air: links between the environment and cardiovascular disease
  255. Air pollution, chronic smoking, and mortality
  256. Vascular Inflammation and Oxidative Stress: Major Triggers for Cardiovascular Disease
  257. Center for Thrombosis and Hemostasis Mainz
  258. Identification of acute myocardial infarction in elderly patients using optimized highly sensitive troponin I thresholds
  259. Subtherapeutic Anticoagulation Control under Treatment with Vitamin K-Antagonists—Data from a Specialized Coagulation Service
  260. Vision-related quality of life considering both eyes: results from the German population-based Gutenberg Health Study (GHS)
  261. Choroidal thickness is associated with cardiovascular risk factors and cardiac health: the Gutenberg Health Study
  262. 5-Year Experience of In-Hospital Outcomes After Percutaneous Left Atrial Appendage Closure in Germany
  263. Hybrid Coronary Percutaneous Treatment with Metallic Stents and Everolimus-Eluting Bioresorbable Vascular Scaffolds: 2-years Results from the GABI-R Registry
  264. Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial
  265. Trends in thrombolytic treatment and outcomes of acute pulmonary embolism in Germany
  266. Relative Telomere Length and Cardiovascular Risk Factors
  267. Cardiac arrest in takotsubo syndrome: results from the InterTAK Registry
  268. Association of Low Birth Weight With Altered Corneal Geometry and Axial Length in Adulthood in the German Gutenberg Health Study
  269. Chronic occupational noise exposure: Effects on DNA damage, blood pressure, and serum biochemistry
  270. Incidence of infective endocarditis before and after the guideline modification regarding a more restrictive use of prophylactic antibiotics therapy in the USA and Europe
  271. Noninvasive peripheral vascular function and atrial fibrillation in the general population
  272. Incidental Finding of Strut Malapposition Is a Predictor of Late and Very Late Thrombosis in Coronary Bioresorbable Scaffolds
  273. The prevalence of visual impairment in the adult population
  274. Income and education predict elevated depressive symptoms in the general population: results from the Gutenberg health study
  275. Lysed Erythrocyte Membranes Promote Vascular Calcification
  276. Contribution of airborne desert dust to air quality and cardiopulmonary disease
  277. A sequential interferon gamma directed chemotactic cellular immune response determines survival and cardiac function post myocardial infarction
  278. Heart rate, mortality, and the relation with clinical and subclinical cardiovascular diseases: results from the Gutenberg Health Study
  279. The cardiovascular effects of noise
  280. Environmental noise induces the release of stress hormones and inflammatory signaling molecules leading to oxidative stress and vascular dysfunction—Signatures of the internal exposome
  281. Incidence and in-hospital safety outcomes of patients undergoing percutaneous mitral valve edge-to-edge repair using MitraClip: five-year German national patient sample including 13,575 implants
  282. Indikation zur Therapie der Trikuspidalklappe bei rechts- und/oder linksventrikulären Erkrankungen
  283. Syncope in the German Nationwide inpatient sample – Syncope in atrial fibrillation/flutter is related to pulmonary embolism and is accompanied by higher in-hospital mortality
  284. Bioresorbable vascular scaffolds for percutaneous treatment of chronic total coronary occlusions: a meta-analysis
  285. Somatic symptom load in men and women from middle to high age in the Gutenberg Health Study - association with psychosocial and somatic factors
  286. The diagnostic performance of renal function-adjusted D-dimer testing in individuals suspected of having venous thromboembolism
  287. Cardiovascular disease burden from ambient air pollution in Europe reassessed using novel hazard ratio functions
  288. Inducible Knockdown of Endothelial Protein Tyrosine Phosphatase-1B Promotes Neointima Formation in Obese Mice by Enhancing Endothelial Senescence
  289. Antagonization of IL-17A Attenuates Skin Inflammation and Vascular Dysfunction in Mouse Models of Psoriasis
  290. Impact of symptomatic atherosclerosis in patients with pulmonary embolism
  291. Left ventricular geometry and function in early repolarization: results from the population-based Gutenberg Health Study
  292. Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events
  293. Antihypertensive Decapeptide From Cyanobacterium Spirulina platensis
  294. Common Genetic Variation in Relation to Brachial Vascular Dimensions and Flow-Mediated Vasodilation
  295. Impact of chronic obstructive pulmonary disease on the outcomes of patients with peripheral artery disease
  296. Die interdisziplinäre Notaufnahme im Zusammenspiel mit Chest Pain Units, Brustschmerzambulanzen und Cardiac Arrest Centern
  297. Assessing Planning Ability Across the Adult Life Span in a Large Population-Representative Sample: Reliability Estimates and Normative Data for the Tower of London (TOL-F) Task
  298. Procedural Predictors for Bioresorbable Vascular Scaffold Thrombosis: Analysis of the Individual Components of the “PSP” Technique
  299. Outcomes Associated With Cardiogenic Shock in Takotsubo Syndrome
  300. Endothelial α1AMPK modulates angiotensin II-mediated vascular inflammation and dysfunction
  301. New Therapeutic Implications of Endothelial Nitric Oxide Synthase (eNOS) Function/Dysfunction in Cardiovascular Disease
  302. Direct oral anticoagulants and vitamin K antagonists are linked to differential profiles of cardiac function and lipid metabolism
  303. Endothelial Leptin Receptor Deletion Promotes Cardiac Autophagy and Angiogenesis Following Pressure Overload by Suppressing Akt/mTOR Signaling
  304. Impact of atrial fibrillation on in-hospital mortality of ischemic stroke patients and identification of promoting factors of atrial thrombi – Results from the German nationwide inpatient sample and a single-center retrospective cohort
  305. The Endothelin Receptor Antagonist Macitentan Improves Isosorbide-5-Mononitrate (ISMN) and Isosorbide Dinitrate (ISDN) Induced Endothelial Dysfunction, Oxidative Stress, and Vascular Inflammation
  306. Oxidative Stress in Cardiac Tissue of Patients Undergoing Coronary Artery Bypass Graft Surgery: The Effects of Overweight and Obesity
  307. Relevance of Polypharmacy for Clinical Outcome in Patients Receiving Vitamin K Antagonists
  308. Predictors of stent thrombosis and their implications for clinical practice
  309. Lipid-Mediated Relation between Tissue Factor Pathway Inhibitor Activity and Cardiovascular Risk Factors and Diseases in a Large Population Sample
  310. Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
  311. Interferon- and ribavirin-free therapy with new direct acting antivirals (DAA) for chronic hepatitis C improves vascular endothelial function
  312. Syncope in haemodynamically stable and unstable patients with acute pulmonary embolism – Results of the German nationwide inpatient sample
  313. Management of Oral Anti-Coagulation in Patients with Heart Failure—Insights from the ThrombEVAL Study
  314. Morphine and Ticagrelor Interaction in Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: ATLANTIC-Morphine
  315. Cardiac Troponins for the Diagnosis of Acute Myocardial Infarction in Chronic Kidney Disease
  316. Characteristics and outcome of patients with complex coronary lesions treated with bioresorbable scaffolds: three-year follow-up in a cohort of consecutive patients
  317. Predictors of bioresorbable scaffold failure in STEMI patients at 3 years follow-up
  318. Cardiovascular risk factors are important determinants of platelet-dependent thrombin generation in adult survivors of childhood cancer
  319. New onset of depression in aging women and men: contributions of social, psychological, behavioral, and somatic predictors in the community – CORRIGENDUM
  320. Intake of Vitamin K Antagonists and Worsening of Cardiac and Vascular Disease: Results From the Population‐Based Gutenberg Health Study
  321. First percutaneous COMBO therapy of tricuspid regurgitation using direct annuloplasty and staged edge-to-edge repair in a surgical-like Clover technique
  322. TCT-720 Right ventricular function as a predictor for mortality in TAVI patients
  323. Cross-Sectional Associations between Homoarginine, Intermediate Phenotypes, and Atrial Fibrillation in the Community—The Gutenberg Health Study
  324. Is assessment of depression equivalent for migrants of different cultural backgrounds? Results from the German population-based Gutenberg Health Study (GHS)
  325. Double hazard of smoking and alcohol on vascular function in adolescents
  326. New onset of depression in aging women and men: contributions of social, psychological, behavioral, and somatic predictors in the community
  327. Novel DNA Methylation Sites Influence GPR15 Expression in Relation to Smoking
  328. Effects of gaseous and solid constituents of air pollution on endothelial function
  329. Annoyance to different noise sources is associated with atrial fibrillation in the Gutenberg Health Study
  330. Predictors of early scaffold thrombosis
  331. Long-Term Prognosis of Patients With Takotsubo Syndrome
  332. The German CPU registry: Comparison of smokers and nonsmokers
  333. PR interval genome-wide association meta-analysis identifies 50 loci associated with atrial and atrioventricular electrical activity
  334. A first dedicated Heart Valve Unit
  335. α1AMPK deletion in myelomonocytic cells induces a pro-inflammatory phenotype and enhances angiotensin II-induced vascular dysfunction
  336. Atrial Fibrillation Manifestations Risk Factors and Sex Differences in a Population-Based Cohort (From the Gutenberg Health Study)
  337. Prevalence of depression and anxiety among participants with glaucoma in a population-based cohort study: The Gutenberg Health Study
  338. Crucial role for Nox2 and sleep deprivation in aircraft noise-induced vascular and cerebral oxidative stress, inflammation, and gene regulation
  339. The endothelial tumor suppressor p53 is essential for venous thrombus formation in aged mice
  340. Pulmonary Arterial Hypertension and Endothelial Dysfunction Is Linked to NADPH Oxidase-Derived Superoxide Formation in Venous Thrombosis and Pulmonary Embolism in Mice
  341. Sustained atrial fibrillation increases the risk of anticoagulation-related bleeding in heart failure
  342. Role of endothelial and macrophage tetrahydrobiopterin in development and progression of atherosclerosis: BH4 puzzle solved?
  343. Adjusted Troponin I for Improved Evaluation of Patients with Chest Pain
  344. Association of ocular, cardiovascular, morphometric and lifestyle parameters with retinal nerve fibre layer thickness
  345. Prevalence of glaucoma in Germany: results from the Gutenberg Health Study
  346. Therapeutic implications of a combined diagnostic workup including endomyocardial biopsy in an all-comer population of patients with heart failure: a retrospective analysis
  347. Three-years outcomes of diabetic patients treated with coronary bioresorbable scaffolds
  348. Bioresorbable everolimus-eluting vascular scaffold for patients presenting with non STelevation-acute coronary syndrome: A three-years follow-up1
  349. Environmental stressors and cardiovascular risk: Impact of environmental noise exposure on vascular oxidative stress and damage
  350. Abstract 030: IL-17A Induces Vascular Dysfunction via Downregulation of eNOS Expression
  351. Multiple systemic embolic events in a patient undergoing primary percutaneous coronary intervention
  352. Abstract 147: The Role of Thrombin Generation in Cardiovascular Disease and Mortality - Results from the Population-based Gutenberg Health Study
  353. Associations between degree and sub-dimensions of depression and metabolic syndrome (MetS) in the community: results from the Gutenberg Health Study (GHS)
  354. Clinical Determinants of Thrombin Generation Measured in Presence and Absence of Platelets—Results from the Gutenberg Health Study
  355. Clinical, Angiographic, and Procedural Correlates of Very Late Absorb Scaffold Thrombosis
  356. Corrigendum to “European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)” [Redox Biol. 13 (2017) 94–162]
  357. Acute deep vein thrombosis suppresses peripheral T cell effector function
  358. The Adverse Effects of Environmental Noise Exposure on Oxidative Stress and Cardiovascular Risk
  359. Environmental Stressors and Their Impact on Health and Disease with Focus on Oxidative Stress
  360. Relations of Sex to Diagnosis and Outcomes in Acute Coronary Syndrome
  361. Guideline-adherence regarding critical time intervals in the German Chest Pain Unit registry
  362. Coagulation and inflammation in long‐term cancer survivors: results from the adult population
  363. Burden of cardiovascular risk factors and cardiovascular disease in childhood cancer survivors: data from the German CVSS-study
  364. Epidemiology of traffic noise and cardiometabolic disease
  365. Pathophysiology of noise-induced cardiovascular diseases
  366. Introduction
  367. Future perspectives
  368. Summary
  369. Conclusions
  370. Strategies to mitigate cardiovascular effects of noise and air pollution
  371. Development and challenges over the next decade
  372. Inorganic nitrite and nitrate in cardiovascular therapy: A better alternative to organic nitrates as nitric oxide donors?
  373. Invasive treatment of NSTEMI patients in German Chest Pain Units – Evidence for a treatment paradox
  374. The potential of aldehyde dehydrogenase 2 as a therapeutic target in cardiovascular disease
  375. Lack of T-bet reduces monocytic interleukin-12 formation and accelerates thrombus resolution in deep vein thrombosis
  376. Environmental Noise and the Cardiovascular System
  377. Editorial commentary: The air that I breathe……………..makes me sick!
  378. Sex-specific differences in mortality and the obesity paradox of patients with myocardial infarction ages >70 y
  379. Prävention von Herz-Kreislauf-Erkrankungen
  380. Gender differences in bicycle exercise stress echocardiography testing
  381. Gender-differences in prevalence and outcome of ischemic stroke and promoting factors of atrial thrombi
  382. PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock
  383. Einschätzung von Ärzten zur medizinischen Versorgung mit oralen Antikoagulanzien
  384. Characteristics, Predictors, and Mechanisms of Thrombosis in Coronary Bioresorbable Scaffolds
  385. Clinical restenosis and its predictors after implantation of everolimus-eluting bioresorbable vascular scaffolds: results from GABI-R
  386. Everolimus-eluting bioresorbable scaffolds in patients with coronary artery disease: results from the German-Austrian ABSORB RegIstRy (GABI-R)
  387. Successful percutaneous coronary intervention for an in-stent chronic total occlusion in a patient with dextrocardia: a case report
  388. Pitfalls of cannulation for extracorporeal life support: review of the literature and illustrative case presentation
  389. The SGLT2 Inhibitor Empagliflozin Improves the Primary Diabetic Complications in ZDF Rats
  390. Refractive, corneal, and ocular residual astigmatism: distribution in a German population and age dependency—the Gutenberg Health Study
  391. First in human transcatheter COMBO mitral valve repair with direct ring annuloplasty and neochord leaflet implantation to treat degenerative mitral regurgitation: feasibility of the simultaneous toolbox concept guided by 3D echo and computed tomography...
  392. Clinical outcomes of patients with diabetes mellitus treated with Absorb bioresorbable vascular scaffolds: a subanalysis of the European Multicentre GHOST-EURegistry
  393. Intramyocardial inflammation predicts adverse outcome in patients with cardiac AL amyloidosis
  394. Time Response of Oxidative/Nitrosative Stress and Inflammation in LPS-Induced Endotoxaemia—A Comparative Study of Mice and Rats
  395. Emotional and tangible social support in a German population-based sample: Development and validation of the Brief Social Support Scale (BS6)
  396. Basic in vitro Characterization of the Vasodilatory Potential of 2-Aminoethyl Nitrate Fixed-Dose Combinations with Cilostazol, Metoprolol and Valsartan
  397. Urinary neutrophil gelatinase-associated lipocalin and cystatin C compared to the estimated glomerular filtration rate to predict risk in patients with suspected acute myocardial infarction
  398. European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)
  399. The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats
  400. Twelve-month outcomes after bioresorbable vascular scaffold implantation in patients with acute coronary syndromes. Data from the European Multicenter GHOST-EU Extended Registry
  401. Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial
  402. CD40L controls obesity-associated vascular inflammation, oxidative stress and endothelial dysfunction in mice - translational aspects for man
  403. Cardiovascular Biomarkers in Hypertensive Patients with Medical Treatment—Results from the Randomized TEAMSTA Protect I Trial
  404. Environmental Factors and Hypertension
  405. Subclinical levels of anxiety but not depression are associated with planning performance in a large population-based sample
  406. Incidence, Clinical Presentation, and Predictors of Clinical Restenosis in Coronary Bioresorbable Scaffolds
  407. Selective Deletion of Leptin Signaling in Endothelial Cells Enhances Neointima Formation and Phenocopies the Vascular Effects of Diet-Induced Obesity in Mice
  408. Refractive, corneal and ocular residual astigmatism: distribution in a German population and age-dependency - the Gutenberg health study
  409. Successful transcatheter aortic valve-in-valve implantation in a patient having a chronic type A aortic dissection
  410. The National Eye Institute 25-Item Visual Function Questionnaire (NEI VFQ-25) – reference data from the German population-based Gutenberg Health Study (GHS)
  411. GDF-15 predicts cardiovascular events in acute chest pain patients
  412. Peripheral artery disease, redox signaling, oxidative stress – Basic and clinical aspects
  413. Redox regulation of cardiovascular inflammation – Immunomodulatory function of mitochondrial and Nox-derived reactive oxygen and nitrogen species
  414. Taking up the cudgels for the traditional reactive oxygen and nitrogen species detection assays and their use in the cardiovascular system
  415. Relation between Arterial Stiffness and Markers of Inflammation and Hemostasis – Data from the Population-based Gutenberg Health Study
  416. Age-related diagnostic value of D-dimer testing and the role of inflammation in patients with suspected deep vein thrombosis
  417. Impact of Oxidative Stress on the Heart and Vasculature
  418. Taking up the cudgels for the traditional reactive oxygen and nitrogen species detection assays and their use in the cardiovascular system
  419. Environmental stressors and cardiovascular disease: the evidence is growing
  420. Transapical implantation of a transcatheter aortic valve prosthesis into a mitral annuloplasty ring guided by real-time three-dimensional cardiac computed tomography–fluoroscopy fusion imaging
  421. Long-term outcome of bioresorbable vascular scaffolds for the treatment of coronary artery disease: a meta-analysis of RCTs
  422. e-Health-based management of patients receiving oral anticoagulation therapy: results from the observational thrombEVAL study
  423. Does endothelial tetrahydrobiopterin control the endothelial NO synthase coupling state in arterial resistance arteries?
  424. Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease
  425. Transcatheter transapical left ventricle remodelling in ischaemic cardiomyopathy with apical aneurysm using 3rd generation 3D cardiac computed tomography fusion imaging
  426. Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
  427. Chest Pain Unit Network in Germany
  428. FEV1 and FVC predict all-cause mortality independent of cardiac function — Results from the population-based Gutenberg Health Study
  429. Look Out—A Trap in the Cardiac Cath Lab
  430. Large-scale genome-wide analysis identifies genetic variants associated with cardiac structure and function
  431. Comparison of transcatheter aortic valve implantation with the newest-generation Sapien 3 vs. Direct Flow Medical valve in a single center cohort
  432. New-onset third-degree atrioventricular block because of autoimmune-induced myositis under treatment with anti-programmed cell death-1 (nivolumab) for metastatic melanoma
  433. Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development and internal validation of the PSP score
  434. The impact of pseudophakia on vision-related quality of life in the general population – The Gutenberg Health Study
  435. The Prevalence of Glaucoma in Young People
  436. Loneliness in the general population: prevalence, determinants and relations to mental health
  437. Relations of Metabolically Healthy and Unhealthy Obesity to Digital Vascular Function in Three Community‐Based Cohorts: A Meta‐Analysis
  438. Percutaneous transvenous direct annuloplasty of a human tricuspid valve using the Valtech Cardioband
  439. Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions
  440. Characterization and referral patterns of ST-elevation myocardial infarction patients admitted to chest pain units rather than directly to catherization laboratories. Data from the German Chest Pain Unit Registry
  441. Brustschmerzambulanzen (BSA) und Chest Pain Units (CPU) – eine gelungene interaktive Kombination weiter auf dem Vormarsch
  442. Effects of noise on vascular function, oxidative stress, and inflammation: mechanistic insight from studies in mice
  443. Editor’s Choice-The organization of chest pain units: Position statement of the Acute Cardiovascular Care Association
  444. Platelet-localized FXI promotes a vascular coagulation-inflammatory circuit in arterial hypertension
  445. Both flow-mediated dilation and constriction are associated with changes in blood flow and shear stress: Two complementary perspectives on endothelial function
  446. Mean Platelet Volume and Arterial Stiffness – Clinical Relationship and Common Genetic Variability
  447. Supervised exercise training in peripheral arterial disease increases vascular shear stress and profunda femoral artery diameter
  448. Pharmacology of Nitrovasodilators
  449. Noise Pollution and Arterial Hypertension
  450. Role of Protein Kinase C and Nox2-Derived Reactive Oxygen Species Formation in the Activation and Maturation of Dendritic Cells by Phorbol Ester and Lipopolysaccharide
  451. Steeper Iris Conicity Is Related to a Shallower Anterior Chamber: The Gutenberg Health Study
  452. Dabigatran after Short Heparin Anticoagulation for Acute Intermediate-Risk Pulmonary Embolism: Rationale and Design of the Single-Arm PEITHO-2 Study
  453. Pentaerythritol Tetranitrate In Vivo Treatment Improves Oxidative Stress and Vascular Dysfunction by Suppression of Endothelin-1 Signaling in Monocrotaline-Induced Pulmonary Hypertension
  454. Absence of transforming growth factor beta 1 in murine platelets reduces neointima formation without affecting arterial thrombosis
  455. Biomarkers for characterization of heart failure – Distinction of heart failure with preserved and reduced ejection fraction
  456. First Evidence of Complete Resorption 4 Years After Bioresorbable Scaffold Implantation in the Setting of ST-Segment Elevation Myocardial Infarction
  457. From thrombosis to fibrosis in chronic thromboembolic pulmonary hypertension
  458. Prospective, randomised trial of the time dependent antiplatelet effects of 500 mg and 250 mg acetylsalicylic acid i. v. and 300 mg p. o. in ACS (ACUTE)
  459. Temporal Trends in the Prevalence of Infective Endocarditis in Germany Between 2005 and 2014
  460. Pheochromocytoma triggers takotsubo syndrome complicated by cerebral and peripheral embolic events
  461. Midregional proadrenomedullin and growth differentiation factor-15 are not influenced by obesity in heart failure patients
  462. TCT-404 ABSORB bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in ST-segment elevation myocardial infarction (BVS EXAMINATION study): 2-year results from a propensity score matched comparison
  463. TCT-401 Bioresorbable Scaffolds And Thrombosis: Insights From The GHOST-EU (Gauging coronary Healing with biOresorbable Scaffolding plaTforms in Europe) Registry
  464. A rare cause of excruciating chest pain mimicking acute coronary syndrome
  465. Cardiac arrhythmias in patients with Danon disease
  466. High-sensitivity troponin and novel biomarkers for the early diagnosis of non-ST-segment elevation myocardial infarction in patients with atrial fibrillation
  467. On versus off-hour care of patients with acute coronary syndrome and persistent ST-segment elevation in certified German chest pain units
  468. Gender-specific diagnostic performance of a new high-sensitivity cardiac troponin I assay for detection of acute myocardial infarction
  469. NOX2 amplifies acetaldehyde-mediated cardiomyocyte mitochondrial dysfunction in alcoholic cardiomyopathy
  470. [PP.35.03] ALDOSTERONE, RENIN AND THE ALDOSTERONE-TO-RENIN-RATIO
  471. Subclinical impairment of lung function is related to mild cardiac dysfunction and manifest heart failure in the general population
  472. Transcatheter aortic valve implantation with the new-generation Evolut R™
  473. Gut Microbiota Promote Angiotensin II–Induced Arterial Hypertension and Vascular Dysfunction
  474. Glucagon-like peptide-1 receptor signalling reduces microvascular thrombosis, nitro-oxidative stress and platelet activation in endotoxaemic mice
  475. Impact of overlapping on 1-year clinical outcomes in patients undergoing everolimus-eluting bioresorbable scaffolds implantation in routine clinical practice: Insights from the European multicenter GHOST-EU registry
  476. Impact of postdilatation on performance of bioresorbable vascular scaffolds in patients with acute coronary syndrome compared with everolimus-eluting stents: A propensity score-matched analysis from a multicenter “real-world” registry
  477. Kriterien der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e. V. für „Brustschmerz-Ambulanzen“
  478. Early and midterm outcomes of bioresorbable vascular scaffolds for ostial coronary lesions: insights from the GHOST-EU registry
  479. Reply
  480. Environmental stressors and cardio-metabolic disease: part I–epidemiologic evidence supporting a role for noise and air pollution and effects of mitigation strategies
  481. Environmental stressors and cardio-metabolic disease: part II–mechanistic insights
  482. Airborne disease: a case of a Takotsubo cardiomyopathie as a consequence of nighttime aircraft noise exposure
  483. Bioresorbable vascular scaffold use for coronary bifurcation lesions: A substudy from GHOST EU registry
  484. Distribution of Anterior Chamber Angle Width and Correlation With Age, Refraction, and Anterior Chamber Depth—The Gutenberg Health Study
  485. Current and cumulative night shift work and subclinical atherosclerosis: results of the Gutenberg Health Study
  486. Targeting vascular (endothelial) dysfunction
  487. ABSORB bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in ST-segment elevation myocardial infarction (BVS EXAMINATION study): 2-Year results from a propensity score matched comparison
  488. Association of Type D personality with cognitive functioning in individuals with and without cardiovascular disease — The Gutenberg Health Study
  489. Circulating microRNAs strongly predict cardiovascular death in patients with coronary artery disease—results from the large AtheroGene study
  490. Nitroglycerin induces DNA damage and vascular cell death in the setting of nitrate tolerance
  491. Differences between perivascular adipose tissue surrounding the heart and the internal mammary artery: possible role for the leptin-inflammation-fibrosis-hypoxia axis
  492. A systematic diagnostic and therapeutic approach for the treatment of patients after cardio-pulmonary resuscitation: a prospective evaluation of 212 patients over 5 years
  493. Noise Annoyance is Associated With Depression and Anxiety in the General Population- the Contribution of Aircraft Noise
  494. Endothelial deletion of protein tyrosine phosphatase-1B protects against pressure overload-induced heart failure in mice
  495. Noise Annoyance Is Associated with Depression and Anxiety in the General Population- The Contribution of Aircraft Noise
  496. Serial assessments of microvascular obstruction by contrast-enhanced magnetic resonance predict contractile recovery and clinical outcome after reperfused acute myocardial infarction
  497. Hypertension is strongly associated with false-positive bicycle exercise stress echocardiography testing results
  498. Troponin I Assay for Identification of a Significant Coronary Stenosis in Patients with Suspected Acute Myocardial Infarction and Wide QRS Complex
  499. Leukocyte–platelet aggregates—a phenotypic characterization of different stages of peripheral arterial disease
  500. Risk factors for heart failure are associated with alterations of the LV end-diastolic pressure–volume relationship in non-heart failure individuals: data from a large-scale, population-based cohort
  501. Formation of 2-nitrophenol from salicylaldehyde as a suitable test for low peroxynitrite fluxes
  502. Low Homoarginine Levels in the Prognosis of Patients With Acute Chest Pain
  503. PO-58 - Cardiovascular risk profile in survivors of adult cancer - results from the general population study
  504. BENCHMARKING IN THE MYOCARDIAL INFARCTION REGISTRY RHEINLAND-PFALZ (MIR-RLP) RESULTED IN INCREASE IN PRE-HOSPITAL ECG-RECORDING AND REDUCTION IN ISCHEMIC TIME TO REPERFUSION IN STEMI
  505. Cardiac Computed Tomography in Certified German Chest Pain Units
  506. Bioresorbable Coronary Scaffold Thrombosis
  507. 1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents
  508. Crosstalk of mitochondria with NADPH oxidase via reactive oxygen and nitrogen species signalling and its role for vascular function
  509. Influence of exercise training on proangiogenic TIE-2 monocytes and circulating angiogenic cells in patients with peripheral arterial disease
  510. Erratum to: Criteria of the German Society of Cardiology for the establishment of chest pain units: update 2015
  511. Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function
  512. Lumen Size Matters
  513. Sex-specific differences in genetic and nongenetic determinants of mean platelet volume: results from the Gutenberg Health Study
  514. Comparison of risk assessment strategies for not-high-risk pulmonary embolism
  515. Reference intervals of plasma homoarginine from the German Gutenberg Health Study
  516. ADMA and arginine derivatives in relation to non-invasive vascular function in the general population
  517. Evaluation of the short- and long-term safety and therapy outcomes of the everolimus-eluting bioresorbable vascular scaffold system in patients with coronary artery stenosis: Rationale and design of the German–Austrian ABSORB RegIstRy (GABI-R)
  518. ADMA, subclinical changes and atrial fibrillation in the general population
  519. Severe Prinzmetal-Type Coronary Artery Spasm Causing Recurrent ST-Segment Elevation and Reversible Obstruction of a Bioresorbable Scaffold
  520. Distribution of antiphospholipid antibodies in a large population-based German cohort
  521. The Use of Echocardiography in Certified Chest Pain Units: Results from the German Chest Pain Unit Registry
  522. Platelet-Localized FXI Promotes a Glycoprotein Ib Alpha Dependent Feedback Loop in Arterial Hypertension and Vascular Inflammation
  523. Uncoupling of Endothelial Nitric Oxide Synthase in Perivascular Adipose Tissue of Diet-Induced Obese MiceSignificance
  524. Coronary evaginations and peri-scaffold aneurysms following implantation of bioresorbable scaffolds: incidence, outcome, and optical coherence tomography analysis of possible mechanisms
  525. History of deep vein thrombosis is a discriminator for concomitant atrial fibrillation in pulmonary embolism
  526. Heme oxygenase-1 suppresses a pro-inflammatory phenotype in monocytes and determines endothelial function and arterial hypertension in mice and humans
  527. Redox Regulation of Dihydrofolate Reductase: Figure.
  528. Inflammation is associated with a reduced number of pro-angiogenic Tie-2 monocytes and endothelial progenitor cells in patients with critical limb ischemia
  529. Primary Persistent Atrial Fibrillation: A Distinct Arrhythmia Subentity of an Ablation Population
  530. Organic Nitrate Therapy, Nitrate Tolerance, and Nitrate-Induced Endothelial Dysfunction: Emphasis on Redox Biology and Oxidative Stress
  531. Research highlights in interventional cardiology
  532. TCT-12 Impact of overlap on long-term clinical outcomes in patients undergoing everolimus-eluting bioresorbable vascular scaffolds implantation in routine clinical practice: insights from the European multicenter GHOST-EU registry
  533. Optical Coherence Tomography Findings in Bioresorbable Vascular Scaffolds Thrombosis
  534. Admission heart rate in relation to presentation and prognosis in patients with acute myocardial infarction
  535. Molecular Characterization of the NLRC4 Expression in Relation to Interleukin-18 LevelsCLINICAL PERSPECTIVE
  536. Arrhythmia Termination Versus Elimination of Dormant Pulmonary Vein Conduction as a Procedural End Point of Catheter Ablation for Paroxysmal Atrial Fibrillation
  537. Exploiting the Pleiotropic Antioxidant Effects of Established Drugs in Cardiovascular Disease
  538. Guideline-adherence and perspectives in the acute management of unstable angina – Initial results from the German chest pain unit registry
  539. Effect of soluble guanylyl cyclase activator and stimulator therapy on nitroglycerin-induced nitrate tolerance in rats
  540. „Do not rescuscitate“ – Auswirkungen der Einführung eines standardisierten Formulars auf Therapiebegrenzungen in der klinischen Praxis
  541. The Incidence of Audible Steam Pops Is Increased and Unpredictable With the ThermoCool® Surround Flow Catheter During Left Atrial Catheter Ablation: A Prospective Observational Study
  542. Identification of acute myocardial infarction in patients with atrial fibrillation and chest pain with a contemporary sensitive troponin I assay
  543. Estimation of Values below the Limit of Detection of a Contemporary Sensitive Troponin I Assay Improves Diagnosis of Acute Myocardial Infarction
  544. Angiotensin II to macrophage: Will you polarize? and when?
  545. Criteria of the German Society of Cardiology for the establishment of chest pain units: update 2014
  546. Pathophysiological role of oxidative stress in systolic and diastolic heart failure and its therapeutic implications
  547. Rationale and design of three observational, prospective cohort studies including biobanking to evaluate and improve diagnostics, management strategies and risk stratification in venous thromboembolism: the VTEval Project
  548. Rationale and design of the RE-LATED AF—AFNET 7 trial: REsolution of Left atrial-Appendage Thrombus—Effects of Dabigatran in patients with Atrial Fibrillation
  549. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
  550. PHQ-2 and GAD-2 scores predict mortality in patients undergoing oral anticoagulation
  551. Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
  552. Clinical, Angiographic, Functional, and Imaging Outcomes 12 Months After Implantation of Drug-Eluting Bioresorbable Vascular Scaffolds in Acute Coronary Syndromes
  553. Symptoms of depression and anxiety predict mortality in patients undergoing oral anticoagulation: Results from the thrombEVAL study program
  554. Distribution, genetic and cardiovascular determinants of FVIII:c — Data from the population-based Gutenberg Health Study
  555. Cardiac MR enables diagnosis in 90% of patients with acute chest pain, elevated biomarkers and unobstructed coronary arteries
  556. Profile of the Immune and Inflammatory Response in Individuals With Prediabetes and Type 2 Diabetes
  557. The Ophthalmic Branch of the Gutenberg Health Study: Study Design, Cohort Profile and Self-Reported Diseases
  558. Change of walking distance in intermittent claudication: impact on inflammation, oxidative stress and mononuclear cells: a pilot study
  559. CardioPulse Articles
  560. Timing of Percutaneous Coronary Intervention in Troponin-negative Patients With Acute Coronary Syndrome Without Persistent ST-segment Elevation
  561. Correction
  562. THROMBOSIS AFTER BIORESORBABLE VASCULAR SCAFFOLD IMPLANTATION: ANGIOGRAPHIC AND OCT FINDINGS
  563. Kriterien der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung für „Chest Pain Units“
  564. Feasibility and safety of left ventricular endomyocardial biopsy via transradial access: Technique and initial experience
  565. The German CPU Registry: Dyspnea independently predicts negative short-term outcome in patients admitted to German Chest Pain Units
  566. Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry
  567. Gliptin and GLP‐1 analog treatment improves survival and vascular inflammation/dysfunction in animals with lipopolysaccharide‐induced endotoxemia
  568. Akutes Koronarsyndrom (außer STEMI)
  569. High-sensitivity cardiac troponin I in the general population – defining reference populations for the determination of the 99th percentile in the Gutenberg Health Study
  570. Absorb Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Metallic Stent in ST-Segment Elevation Myocardial Infarction: 1-Year Results of a Propensity Score Matching Comparison
  571. Quality of oral anticoagulation with phenprocoumon in regular medical care and its potential for improvement in a telemedicine-based coagulation service – results from the prospective, multi-center, observational cohort study thrombEVAL
  572. Editorial
  573. Organic nitrates: Update on mechanisms underlying vasodilation, tolerance and endothelial dysfunction
  574. Genome-Wide Association Study of l -Arginine and Dimethylarginines Reveals Novel Metabolic Pathway for Symmetric Dimethylarginine
  575. Interleukin 17 Drives Vascular Inflammation, Endothelial Dysfunction, and Arterial Hypertension in Psoriasis-Like Skin Disease
  576. Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure
  577. Multiple Biomarkers and Atrial Fibrillation in the General Population
  578. The Sodium-Glucose Co-Transporter 2 Inhibitor Empagliflozin Improves Diabetes-Induced Vascular Dysfunction in the Streptozotocin Diabetes Rat Model by Interfering with Oxidative Stress and Glucotoxicity
  579. Low IL-10/TNFα Ratio in Patients with Coronary Artery Disease and Reduced Left Ventricular Ejection Fraction with a Poor Prognosis After 10 Years
  580. Maternal Treatment of Spontaneously Hypertensive Rats With Pentaerythritol Tetranitrate Reduces Blood Pressure in Female OffspringNovelty and Significance
  581. Medikamentöse Therapie der stabilen koronaren Herzerkrankung
  582. Die konservative Therapie der stabilen koronaren Herzerkrankung
  583. Stratifizierung des kardiovaskulären Risikos bei Patienten mit Typ-2-Diabetes
  584. Relevance of depression for anticoagulation management in a routine medical care setting: results from the ThrombEVAL study program
  585. Two-vessel peri-scaffold staining and malapposition 12 months after bioresorbable scaffold implantation
  586. Evaluation of an iterative model–based reconstruction algorithm for low-tube-voltage (80 kVp) computed tomography angiography
  587. Immediate, Acute, and Subacute Thrombosis Due to Incomplete Expansion of Bioresorbable Scaffolds
  588. Adrenomedullin and Arterial Stiffness
  589. Ivabradine in Stable Coronary Artery Disease without Clinical Heart Failure
  590. Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
  591. Is At Least One Vitamin Helping Our Vasculature?
  592. TCT-331 Real-World Clinical Experience of Fractional Flow Reserve Assessed With a Rapid Exchange Pressure Sensor on a MicroCatheter
  593. TCT-611 Multimodality assessment 12 months after implantation of a bioresorbable scaffold for the treatment of culprit lesions in myocardial infarction
  594. TCT-403 Peripheral Endothelial Function and Sympathetic Influence on Dermal Microcirculation Correlate with Long-Term Blood Pressure Response in Renal Denervation Patients
  595. Nighttime aircraft noise impairs endothelial function and increases blood pressure in patients with or at high risk for coronary artery disease
  596. Inflammatory Monocytes Determine Endothelial Nitric-oxide Synthase Uncoupling and Nitro-oxidative Stress Induced by Angiotensin II
  597. Associations between Depression and Diabetes in the Community: Do Symptom Dimensions Matter? Results from the Gutenberg Health Study
  598. Interplay of NK cells and monocytes in vascular inflammation and myocardial infarction
  599. Complaints of Sleep Disturbances Are Associated with Cardiovascular Disease: Results from the Gutenberg Health Study
  600. Usefulness of 3D-PISA as compared to guideline endorsed parameters for mitral regurgitation quantification
  601. A 48-year-old woman with panic attacks
  602. eNOS Uncoupling in Cardiovascular Diseases - the Role of Oxidative Stress and Inflammation
  603. Obere gastrointestinale Blutung mit hämorrhagischem Schock am Ende einer Urlaubsreise: Präklinische und innerklinische Versorgung eines gastrointestinalen Notfalls
  604. Effects of empagliflozin on oxidative stress and endothelial dysfunction in STZ-induced Type 1 diabetic rat
  605. Reduction of ICD Shock Burden by Eliminating Back-Up Pacing Induced Ventricular Tachyarrhythmias
  606. Anatomic Stabilization and Functional Normalization of a Ruptured Coronary Plaque 12 Months After Implantation of a Bioresorbable Scaffold
  607. Effects of clopidogrel, prasugrel and ticagrelor on endothelial function, inflammatory and oxidative stress parameters and platelet function in patients undergoing coronary artery stenting for an acute coronary syndrome. A randomised, prospective, cont...
  608. Assessment of microRNAs in patients with unstable angina pectoris
  609. Evaluation of oral anticoagulation therapy: Rationale and design of the thrombEVAL study programme
  610. Aktuelle Koronarstenttechnologie
  611. Cardiovascular effects of environmental noise exposure
  612. Absorb bioresorbable scaffold implantation for the treatment of an ostial chronic total occlusion
  613. IL-6 Regulates Neutrophil Microabscess Formation in IL-17A-Driven Psoriasiform Lesions
  614. Association of multiple biomarkers and classical risk factors with early carotid atherosclerosis: results from the Gutenberg Health Study
  615. CRT-100 A Systematic Diagnostic and Therapeutic Approach for the Treatment of Patients After Cardio-Pulmonary Resuscitation: A Prospective Evaluation of 212 Patients During 5 Years
  616. Antibodies against biologicals and acute coronary syndromes
  617. Glutathione Peroxidase-1 Deficiency Potentiates Dysregulatory Modifications of Endothelial Nitric Oxide Synthase and Vascular Dysfunction in Aging
  618. Mitochondrial Redox Signaling: Interaction of Mitochondrial Reactive Oxygen Species with Other Sources of Oxidative Stress
  619. Molecular Mechanisms of the Crosstalk Between Mitochondria and NADPH Oxidase Through Reactive Oxygen Species—Studies in White Blood Cells and in Animal Models
  620. In vitro and in vivo Characterization of a New Organic Nitrate Hybrid Drug Covalently Bound to Pioglitazone
  621. Vascular Redox Signaling, Redox Switches in Endothelial Nitric Oxide Synthase (eNOS Uncoupling), and Endothelial Dysfunction
  622. Early outcome after implantation of Absorb bioresorbable drug-eluting scaffolds in patients with acute coronary syndromes
  623. Combining Cross-sectional Data on Prevalence with Risk Estimates from a Prediction Model
  624. Deep vein thrombus formation induced by flow reduction in mice is determined by venous side branches
  625. Endothelial dysfunction after stenting and scaffolding of coronary arteries
  626. Predictive value of brachial reactive hyperemia and flow-mediated dilation in stable coronary artery disease
  627. A 56-year-old man with co-prevalence of Leriche syndrome and dilated cardiomyopathy: case report and review
  628. Neue Aspekte in der Pathophysiologie der Herzinsuffizienz sowie deren therapeutische Implikationen
  629. Depression in Atrial Fibrillation in the General Population
  630. Association of high-sensitivity assayed troponin I with cardiovascular phenotypes in the general population: the population-based Gutenberg health study
  631. The Role of DNA Damage in the Pathogenesis of Nitrate Tolerance
  632. Effects of Sodium dependent Glucose Transporter 2 (SGLT2) Inhibition with Empagliflozin on Oxidative Stress and Endothelial Dysfunction in STZ-Induced Type I Diabetic Rat
  633. Comparison of Linagliptin, Sitagliptin and Liraglutide Effects on Survival and Vascular Complications in Experimental Sepsis
  634. Vascular Dysfunction and Oxidative Stress in Diabetic Rats - Comparison of Beneficial Effects of AT1- Receptor Blockade, Calcium Antagonist, or Combination Therapy
  635. TCT-783 Transient and Permanent Cardiac Conduction Abnormalities Following Transcatheter Aortic Valve Implantation
  636. Disease distribution and outcome in troponin-positive patients with or without revascularization in a chest pain unit: results of the German CPU-Registry
  637. Efficacy of the long-acting nitro vasodilator pentaerithrityl tetranitrate in patients with chronic stable angina pectoris receiving anti-anginal background therapy with beta-blockers: a 12-week, randomized, double-blind, placebo-controlled trial
  638. CD40L contributes to angiotensin II-induced pro-thrombotic state, vascular inflammation, oxidative stress and endothelial dysfunction
  639. The German CPU Registry: Comparison of troponin positive to troponin negative patients
  640. Oxidative stress, endothelial biomarkers and non-invasive vascular function in the general population in health and disease
  641. Differential Associations of Depressive Symptom Dimensions with Cardio-Vascular Disease in the Community: Results from the Gutenberg Health Study
  642. GUESS-ing Polygenic Associations with Multiple Phenotypes Using a GPU-Based Evolutionary Stochastic Search Algorithm
  643. Deletion of peroxisome proliferator coactivator-1alpha accelerates angiotensin II induced endothelial dyfunction by increasing mitochondrial oxidative stress
  644. The interaction between circadian rhythms of endothelial function: resting versus recruitable endothelial function
  645. Determinants of arterial stiffness in pre- and postmenopausal women
  646. Cardiovascular effects of nocturnal aircraft noise on healthy volunteers
  647. ABSORB everolimus-eluting bioresorbable vascular scaffold systems for the sealing of unstable plaques
  648. Value of color doppler jet area for grading regurgitation severity in patients with secondary mitral regurgitation - better than its reputation?
  649. Association between genome-wide significant variants on gene expression and glutathione peroxidase-1 levels in the general population
  650. Predictors of self-reported heart failure - results from the Gutenberg Health study
  651. Diagnosis of acute myocardial infarction: super-sensitivity vs. high-sensitivity cardiac troponin I assay
  652. Smoking-induced preconditioning: acute, but not chronic, smoking paradoxically protects the endothelium from ischemia and reperfusion
  653. Effect of antihypertensive treatment with a combination of telmisartan and amlodipine on vascular structure and function
  654. Association between multiple biomarkers and classical risk factors with early carotid atherosclerosis
  655. Gender-specific diagnosis of acute myocardial infarction using high-sensitivity assayed cardiac troponin I
  656. Patients with peripheral arterial disease show an ameliorated proinflammatory status over 12 months non-supervised exercise training parallel to an increased walking distance
  657. Cardiac biomarkers and arterial stiffening: data from the Gutenberg Health study
  658. Defining a reference population to determine the 99th percentile of a contemporary sensitive cardiac troponin I assay
  659. Critical limb ischaemia is characterised by an increased production of whole blood reactive oxygen species and expression of TREM-1 on neutrophils
  660. More answers to the still unresolved question of nitrate tolerance
  661. History of depression but not current depression is associated with signs of atherosclerosis: data from the Gutenberg Health Study
  662. Effect of nighttime aircraft noise exposure on endothelial function and stress hormone release in healthy adults
  663. The impact of gender on fractional flow reserve measurements
  664. Sex differences in noninvasive vascular function in the community
  665. Kardiorenales Syndrom
  666. Association of MR-proadrenomedullin with cardiovascular risk factors and subclinical cardiovascular disease
  667. Angiotensin II–Induced Vascular Dysfunction Depends on Interferon-γ–Driven Immune Cell Recruitment and Mutual Activation of Monocytes and NK-Cells
  668. Association of hypertension with depression in the community
  669. How should I treat a patient with typical angina, typical angiography, negative FFR?
  670. Genome-wide and gene-centric analyses of circulating myeloperoxidase levels in the charge and care consortia
  671. Association between chronic periodontal and apical inflammation and acute myocardial infarction
  672. Protein Tyrosine Nitration and Thiol Oxidation by Peroxynitrite—Strategies to Prevent These Oxidative Modifications
  673. Treatment of coronary bifurcation lesions: stent-covering of the side branch with and without PCI of the side branch: a retrospective analysis of all consecutive patients
  674. Nitrate therapy and nitrate tolerance in patients with coronary artery disease
  675. Angiographic score assessment improves cardiovascular risk prediction: the clinical value of SYNTAX and Gensini application
  676. ACUTE, BUT NOT CHRONIC, SMOKING PARADOXICALLY PROTECTS THE ENDOTHELIUM FROM ISCHEMIA AND REPERFUSION
  677. Effects of telmisartan or amlodipine monotherapy versus telmisartan/amlodipine combination therapy on vascular dysfunction and oxidative stress in diabetic rats
  678. Acute (but not chronic) smoking paradoxically protects the endothelium from ischemia and reperfusion: insight into the “smoking paradox”
  679. Coronary artery disease: seeing or foreseeing?
  680. CRT-37 Treatment Of Coronary Bifurcation Lesions: Stentcovering Of The Side Branch With And Without PCI Of The Side Branch - A Retrospective Analysis Of All Consecutive Patients
  681. An Alternative Pathway of Imiquimod-Induced Psoriasis-Like Skin Inflammation in the Absence of Interleukin-17 Receptor A Signaling
  682. Genome-Wide Haplotype Analysis of Cis Expression Quantitative Trait Loci in Monocytes
  683. Graphical Modeling of Gene Expression in Monocytes Suggests Molecular Mechanisms Explaining Increased Atherosclerosis in Smokers
  684. Immediate effect of the MitraClip(R) procedure on mitral ring geometry in primary and secondary mitral regurgitation
  685. Associations between depression and different measures of obesity (BMI, WC, WHtR, WHR)
  686. Midregional pro-atrial natriuretic peptide in the general population/Insights from the Gutenberg Health Study
  687. Psychodynamic Motivation and Training program (PMT) for the secondary prevention in patients with stable coronary heart disease: study protocol for a randomized controlled trial of feasibility and effects
  688. MR-proANP and MR-proADM for risk stratification of patients with acute chest pain
  689. A 22-year old female with cardiogenic shock due to transplant vasculopathy with severe left main stenosis
  690. Heparin–polynitroxides: Synthesis and preliminary evaluation as cardiovascular EPR/MR imaging probes and extracellular space-targeted antioxidants
  691. Increased Circulating Levels of 3-Nitrotyrosine Autoantibodies
  692. Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1? Deficiency Accelerates Endothelial Dysfunction during Chronic Angiotensin II Treatment by Increasing Mitochondrial Oxidative Stress and Vascular Aging
  693. Prognostic Information of Glycogen Phosphorylase Isoenzyme BB in Patients With Suspected Acute Coronary Syndrome
  694. Enhanced Age-Dependent ENOS Dysfunction and - Uncoupling in Glutathione Peroxidase-1-Deficient Mice
  695. Self-referral to chest pain units: results of the German CPU-registry
  696. Diagnostic and Prognostic Performance of Myeloperoxidase Plasma Levels Compared With Sensitive Troponins in Patients Admitted With Acute Onset Chest Pain
  697. TCT-895 Prediction of implanted TAVI prosthetic size by 3D-TEE assessment
  698. Comprehensive Exploration of the Effects of miRNA SNPs on Monocyte Gene Expression
  699. Multiple Endothelial Biomarkers and Noninvasive Vascular Function in the General Population
  700. Glucose-independent improvement of vascular dysfunction in experimental sepsis by dipeptidyl-peptidase 4 inhibition
  701. Pre- and early in-hospital procedures in patients with acute coronary syndromes: first results of the “German chest pain unit registry”
  702. α1AMP-Activated Protein Kinase Mediates Vascular Protective Effects of Exercise
  703. Genome-wide association study in Han Chinese identifies four new susceptibility loci for coronary artery disease
  704. Impairment of the extrusion transporter for asymmetric dimethyl-l-arginine: A novel mechanism underlying vasospastic angina
  705. Die Gutenberg Gesundheitsstudie
  706. Chronic therapy with isosorbide-5-mononitrate causes endothelial dysfunction, oxidative stress, and a marked increase in vascular endothelin-1 expression
  707. Hyperglycemia and oxidative stress in cultured endothelial cells – a comparison of primary endothelial cells with an immortalized endothelial cell line
  708. Molecular mechanisms of the crosstalk between mitochondrial and NADPH oxidase derived reactive oxygen species in white blood cells — Implications for cardiovascular diseases
  709. Lysozyme M positive monocytes mediate angiotensin II-induced arterial hypertension and vascular dysfunction
  710. Nitroglycerin-induced endothelial dysfunction and tolerance involve adverse phosphorylation and S-glutathionylation of endothelial nitric oxide synthase — Beneficial effects of therapy with the AT1-receptor blocker telmisartan
  711. Comparison of direct and indirect antioxidant effects of linagliptin with other gliptins — Evidence for antioxidant and antiinflammatory properties of linagliptin
  712. Atrial Fibrillation
  713. CardioPulse Articles
  714. Vascular effects and safety of dalcetrapib in patients with or at risk of coronary heart disease: the dal-VESSEL randomized clinical trial
  715. Chronic protection against ischemia and reperfusion-induced endothelial dysfunction during therapy with different organic nitrates
  716. Association Between Chromosome 9p21 Variants and the Ankle-Brachial Index Identified by a Meta-Analysis of 21 Genome-Wide Association Studies
  717. Left atrial appendage occlusion in valvular atrial fibrillation following MitraClip implantation
  718. Oxidative Stress, Endothelial Dysfunction, and Its Impact on Smooth Muscle Signaling
  719. CRP and CD14 polymorphisms correlate with coronary plaque volume in patients with coronary artery disease – IVUS substudy of the ENCORE trials
  720. Characterization of New Organic Nitrate Hybrid Drugs Covalently Bound to Valsartan and Cilostazol
  721. Chronic Inflammatory Cardiomyopathy of Interferon γ–Overexpressing Transgenic Mice Is Mediated by Tumor Necrosis Factor-α
  722. The T Helper 1 Transcription Factor T Box Expressed in T Cells Is a Mediator of Angiotensin II Induced Inflammation, Vascular Dysfunction and Oxidative Stress in the Murine Vasculature
  723. Whole Blood of Patients with Peripheral Arterial Disease Shows an Increased Production of Reactive Oxygen Species and a Proinflammatory Phenotype
  724. CD40 Ligand Deficiency Attenuates Angiotensin II Induced Oxidative Stress and Endothelial Dysfunction in a Murine Model of Arterial Hypertension
  725. Association of soluble endothelial protein C receptor plasma levels and PROCR rs867186 with cardiovascular risk factors and cardiovascular events in coronary artery disease patients: The Athero Gene Study
  726. Apixaban
  727. Endothelial function and hemorheological parameters modulate coronary blood flow in patients without significant coronary artery disease
  728. Evidence of a weak correlation between peripheral endothelial function measures and carotid intima-media thickness
  729. Parameters of blood viscosity do not correlate with the extent of coronary and carotid atherosclerosis and with endothelial function in patients undergoing coronary angiography
  730. Phenotypic characterisation of pro-inflammatory monocytes and dendritic cells in peripheral arterial disease
  731. Type D Personality as a Cardiovascular Risk Marker in the General Population: Results from the Gutenberg Health Study
  732. Serial Changes in Highly Sensitive Troponin I Assay and Early Diagnosis of Myocardial Infarction
  733. Integrating Genome-Wide Genetic Variations and Monocyte Expression Data Reveals Trans-Regulated Gene Modules in Humans
  734. Genome-Wide Association Study for Coronary Artery Calcification With Follow-Up in Myocardial Infarction
  735. Midregional Proadrenomedullin for Prediction of Cardiovascular Events in Coronary Artery Disease: Results from the AtheroGene Study
  736. Reduktion der stationären Verweildauer bei Patienten mit akutem Koronarsyndrom durch Einrichtung einer Chest Pain Unit
  737. Changes in endothelial function in healthy volunteers during soccer World Cup 2010 games
  738. Molecular Mechanisms of the Crosstalk Between Mitochondrial and NADPH Oxidase Derived Reactive Oxygen Species in White Blood Cells – Implications for Cardiovascular Diseases
  739. Glutathione Peroxidase-1-Deficiency Enhances Age-Dependent Vascular Dysfunction
  740. Chronic Therapy With Isosorbide-5-Mononitrate Causes Endothelial Dysfunction, Oxidative Stress and a Marked Increase in Vascular Endothelin-1 Expression
  741. Reconstitution of Myelomonocyte-Depleted Mice With Monocytes, But Not With Neutrophils, Reestablishes Arterial Hypertension and Oxidative Stress in Response To Angiogtensin II
  742. Influence of sex and genetic variability on expression of X-linked genes in human monocytes
  743. Vascular Dysfunction in Experimental Diabetes is Associated With Cardiovascular Oxidative Stress, Loss in ecSOD Activity, Enos Uncoupling and Improved by Pentaerithrityl Tetranitrate – Role for heme oxygenase-1 and NRF2
  744. Intracellular pH: Figure.
  745. Long-range DNA looping and gene expression analyses identify DEXI as an autoimmune disease candidate gene
  746. Differential effects of heart rate reduction with ivabradine in two models of endothelial dysfunction and oxidative stress
  747. Nitroglycerin-Induced Endothelial Dysfunction and Tolerance Involve Adverse Phosphorylation andS-Glutathionylation of Endothelial Nitric Oxide Synthase
  748. Lysozyme M–Positive Monocytes Mediate Angiotensin II–Induced Arterial Hypertension and Vascular Dysfunction
  749. Endothelial function assessment: flow-mediated dilation and constriction provide different and complementary information on the presence of coronary artery disease
  750. Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure
  751. Meta-analysis of genome-wide association studies from the CHARGE consortium identifies common variants associated with carotid intima media thickness and plaque
  752. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk
  753. The Choice of the Filtering Method in Microarrays Affects the Inference Regarding Dosage Compensation of the Active X-Chromosome
  754. Human metabolic individuality in biomedical and pharmaceutical research
  755. Genome-Wide Association Identifies Nine Common Variants Associated With Fasting Proinsulin Levels and Provides New Insights Into the Pathophysiology of Type 2 Diabetes
  756. Biological effects of low-dose radiation: of harm and hormesis
  757. Psychosomatik und Psychotherapie der koronaren Herzerkrankung
  758. Vascular Dysfunction in Experimental Diabetes Is Improved by Pentaerithrityl Tetranitrate but Not Isosorbide-5-Mononitrate Therapy
  759. A Genome-Wide Association Study Identifies LIPA as a Susceptibility Gene for Coronary Artery Disease
  760. β-Blockers in Patients With Intermittent Claudication and Arterial Hypertension
  761. Noninvasive Vascular Function Measurement in the Community
  762. A case of coronary hypersensitivity (Kounis) syndrome associated with mid-ventricular ballooning pattern, intracoronary thrombosis and troponin elevation
  763. Sex Differences in Early Carotid Atherosclerosis (from the Community-Based Gutenberg-Heart Study)
  764. Large-Scale Association Analysis Identifies 13 New Susceptibility Loci for Coronary Artery Disease
  765. Nitrate Therapy
  766. Inorganic Nitrate Therapy Improves Doxorubicin-Induced Cardiomyopathy
  767. Prevalence of distress, comorbid conditions and well being in the general population
  768. Oxidative stress and endothelial dysfunction in hypertension
  769. Making it More Sensitive
  770. MYELOPEROXIDASE AS EARLY DIAGNOSTIC AND PROGNOSTIC MARKER OF ACUTE CORONARY SYNDROME: A HEAD-TO-HEAD COMPARISON WITH HIGH SENSITIVE TROPONIN I
  771. CIRCULATING AND INFILTRATING MONOCYTIC CELLS MEDIATE ANGIOTENSIN-II INDUCED ARTERIAL HYPERTENSION
  772. Betulinic acid protects against cerebral ischemia–reperfusion injury in mice by reducing oxidative and nitrosative stress
  773. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease
  774. α1AMP-Activated Protein Kinase Preserves Endothelial Function During Chronic Angiotensin II Treatment by Limiting Nox2 Upregulation
  775. Oxidative stress and endothelial dysfunction: Therapeutic implications
  776. Regulation of Human Mitochondrial Aldehyde Dehydrogenase (ALDH-2) Activity by Electrophilesin Vitro
  777. Gingival crevicular fluid MMP-8-concentrations in patients after acute myocardial infarction
  778. Vascular Dysfunction in Streptozotocin-Induced Experimental Diabetes Strictly Depends on Insulin Deficiency
  779. Association of Serum Procalcitonin With Cardiovascular Prognosis in Coronary Artery Disease
  780. Chronic pharmacological preconditioning against ischemia
  781. Endothelium and hyperviscosity
  782. Gene therapy with iNOS enhances regional contractility and reduces delayed contrast enhancement in a model of postischemic congestive heart failure
  783. Inflammatory markers and cardiovascular risk in the metabolic syndrome
  784. Peripheral hemorheological and vascular correlates of coronary blood flow
  785. Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies
  786. Tissue Distribution of 5-Hydroxymethylcytosine and Search for Active Demethylation Intermediates
  787. Flow-mediated constriction: further insight into a new measure of vascular function
  788. Rationale and design of dal-VESSEL: a study to assess the safety and efficacy of dalcetrapib on endothelial function using brachial artery flow-mediated vasodilatation
  789. Is oxidative stress a therapeutic target in cardiovascular disease?
  790. Inflammation in right ventricular dysfunction due to thromboembolic pulmonary hypertension
  791. Multiple marker approach to risk stratification in patients with stable coronary artery disease
  792. Tako-Tsubo syndrome: dying of a broken heart?
  793. Atrial fibrosis and atrial fibrillation: The role of the TGF-β1 signaling pathway
  794. Type-D personality and depersonalization are associated with suicidal ideation in the German general population aged 35–74: Results from the Gutenberg Heart Study
  795. Distribution and Categorization of Left Ventricular Measurements in the General Population
  796. A trans-acting locus regulates an anti-viral expression network and type 1 diabetes risk
  797. Mechanismen und klinischer Stellenwert der Nitrattoleranz. Diversität und Nebenwirkungen organischer Nitrate
  798. Therapie der koronaren Herzerkrankung mit NO-Donatoren. Nach wie vor eine wichtige Option
  799. Patientenzufriedenheit beim akuten Koronarsyndrom
  800. Conversion of biliverdin to bilirubin by biliverdin reductase contributes to endothelial cell protection by heme oxygenase-1—evidence for direct and indirect antioxidant actions of bilirubin
  801. Lack of evidence for pleiotropic effects of clopidogrel on endothelial function and inflammation in patients with stable coronary artery disease: results of the double-blind, randomized CASSANDRA study
  802. Das akute Koronarsyndrom
  803. Resveratrol Reverses Endothelial Nitric-Oxide Synthase Uncoupling in Apolipoprotein E Knockout Mice
  804. C4BPB/C4BPA is a new susceptibility locus for venous thrombosis with unknown protein S–independent mechanism: results from genome-wide association and gene expression analyses followed by case-control studies
  805. Contribution of 30 Biomarkers to 10-Year Cardiovascular Risk Estimation in 2 Population Cohorts
  806. P378 RESVERATROL REVERSES eNOS UNCOUPLING: IMPLICATION OF SIRT1
  807. Genetics and Beyond – The Transcriptome of Human Monocytes and Disease Susceptibility
  808. Copeptin Improves Early Diagnosis of Acute Myocardial Infarction
  809. New loci associated with kidney function and chronic kidney disease
  810. Thirty-One Novel Biomarkers as Predictors for Clinically Incident Diabetes
  811. A Follow-Up Study of a Genome-wide Association Scan Identifies a Susceptibility Locus for Venous Thrombosis on Chromosome 6p24.1
  812. A Follow-Up Study of a Genome-wide Association Scan Identifies a Susceptibility Locus for Venous Thrombosis on Chromosome 6p24.1
  813. Pentaerythritol Tetranitrate Improves Angiotensin II–Induced Vascular Dysfunction via Induction of Heme Oxygenase-1
  814. A 34-year-old man with cardiac arrhythmias and lymphadenopathy
  815. Drug-Eluting Stent-Induced Vascular Dysfunction
  816. Serum selenium and prognosis in cardiovascular disease: results from the AtheroGene study
  817. Atrial fibrillation is associated with cardiac hypoxia
  818. Depression and disease severity as correlates of everyday physical activity in heart transplant candidates
  819. Organic Nitrates and Nitrate Tolerance—State of the Art and Future Developments
  820. Lesions of the Mitral Valve as a Cause of Central Retinal Artery Occlusion: Presentation and Discussion of Two Cases
  821. Comparison of Direct and Indirect Antioxidant Effects of Linagliptin (BI 1356, ONDERO) with other Gliptins – Evidence for Anti-inflammatory Properties of Linagliptin
  822. Regulation of Human ALDH-2 Activity by Electrophiles – Implications for Organic Nitrate Induced Tolerance, Oxidative Stress and Reactive Fatty Acid Metabolites in MI
  823. Vascular Dysfunction in Nitroglycerininduced Nitrate Tolerance is Improved by Telmisartan Therapy — Suppression of the RAAS and PKC Pathway
  824. Lysozyme-M Positive Myelomonocytic cells Mediate Angiotensin-II induced Arterial Hypertension
  825. Vascular Dysfunction in Streptozotocininduced Experimental Diabetes Strictly Depends on Insulin Deficiency
  826. Local Transient Myocardial Liposomal Gene Transfer of Inducible Nitric Oxide Synthase Does Not Aggravate Myocardial Function and Fibrosis and Leads to Moderate Neovascularization in Chronic Myocardial Ischemia in Pigs
  827. Endothelial functions: Translating theory into clinical application
  828. Ischemic and non-ischemic preconditioning: Endothelium-focused translation into clinical practice
  829. Improved outcome in acute coronary syndrome by establishing a chest pain unit
  830. Effects of pentaerythritol tetranitrate on endothelial function in coronary artery disease: results of the PENTA study
  831. Endotheliale Dysfunktion: Ursachen und prognostische Bedeutung
  832. Extensive characterization of the human DDAH1 transgenic mice
  833. CYP4A11 polymorphism correlates with coronary endothelial dysfunction in patients with coronary artery disease—The ENCORE Trials
  834. Nachruf zum Tod von Professor Dr. med. Helmut Drexler
  835. Hypoxia and Myocardial Remodeling in Human Cardiac Allografts: A Time-course Study
  836. Differential VASP phosphorylation controls remodeling of the actin cytoskeleton
  837. Nebivolol
  838. Protein Kinase C-Inhibiting Properties of the Losartan Metabolite EXP3179 Make the Difference
  839. Characterization of the Antioxidant Properties of Pentaerithrityl Tetranitrate (PETN)-Induction of the Intrinsic Antioxidative System Heme Oxygenase-1 (HO-1)
  840. Nitrate Reductase Activity of Mitochondrial Aldehyde Dehydrogenase (ALDH-2) as a Redox Sensor for Cardiovascular Oxidative Stress
  841. Entwicklung der Chest-Pain-Units in Deutschland
  842. Die JUPITER-Studie: Antworten und Fragen?
  843. Prognostische Bedeutung der Stressechokardiografie
  844. Lipoprotein-associated phospholipase A2, a marker of vascular inflammation and systemic vulnerability
  845. Effects of selective If-channel inhibition with ivabradine on hemodynamics in a patient with restrictive cardiomyopathy
  846. Sensitive Troponin I Assay in Early Diagnosis of Acute Myocardial Infarction
  847. Evidence for a negative inotropic effect of obesity in human myocardium?☆
  848. Symptomatic and hemodynamic benefit of pentaerythrityl tetranitrate and hydralazine in a case of congestive heart failure
  849. Genetic Variants Associated With Cardiac Structure and Function
  850. Flow-mediated dilation in patients with coronary artery disease is enhanced by high dose atorvastatin compared to combined low dose atorvastatin and ezetimibe: Results of the CEZAR study
  851. Direct measurement of left ventricular outflow tract by transthoracic real-time 3D-echocardiography increases accuracy in assessment of aortic valve stenosis
  852. A new class of organic nitrates: investigations on bioactivation, tolerance and cross-tolerance phenomena
  853. Growth-Differentiation Factor-15 for Risk Stratification in Patients With Stable and Unstable Coronary Heart Disease
  854. A randomized placebo-controlled study on the effect of nifedipine on coronary endothelial function and plaque formation in patients with coronary artery disease: the ENCORE II study
  855. Usefulness of MRI to Differentiate Between Temporary and Long-Term Coronary Artery Occlusion in a Minimally Invasive Model of Experimental Myocardial Infarction
  856. Die Rolle der Chest Pain Unit im Rahmen der Notfallaufnahme
  857. Wie nützlich sind die Algorithmen zur Differentialdiagnostik der monomorphen Tachykardien mit breitem QRS Komplex in kardiologischen Notfällen?
  858. Response to Letter Regarding Article, “Different Calculations of Ankle Brachial Index and Their Impact on Cardiovascular Risk Prediction”
  859. Akuter Thoraxschmerz: Chest-Pain-Unit – die Zertifizierungskampagne der Deutschen Gesellschaft für Kardiologie
  860. Ivabradin – eine neue Therapieoption bei kardiogenem Schock?
  861. Kardiale Notfälle: neue Lösungen für alte Probleme
  862. Wie nützlich sind die Algorithmen zur Differentialdiagnostik der monomorphen Tachykardien mit breitem QRS-Komplex in kardiologischen Notfällen?
  863. Association between Chronic Dental Infection and Acute Myocardial Infarction
  864. Effects of oral niacin on endothelial dysfunction in patients with coronary artery disease: Results of the randomized, double-blind, placebo-controlled INEF study
  865. Long term follow up after percutaneous closure of PFO in 357 patients with paradoxical embolism: Difference in occlusion systems and influence of atrial septum aneurysm
  866. Decision for aggressive therapy in acute pulmonary embolism: implication of elevated troponin T
  867. Monitoring White Blood Cell Mitochondrial Aldehyde Dehydrogenase Activity: Implications for Nitrate Therapy in Humans
  868. From Menace to Marvel
  869. Selektive Herzfrequenzreduktion mit Ivabradin bei der stabilen koronaren Herzerkrankung
  870. Mitochondrial aldehyde dehydrogenase (ALDH-2)—Maker of and marker for nitrate tolerance in response to nitroglycerin treatment
  871. When Metabolism Rules Perfusion
  872. Cystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene study
  873. Nitrate tolerance as a model of vascular dysfunction: Roles for mitochondrial aldehyde dehydrogenase and mitochondrial oxidative stress
  874. Molecular mechanisms underlying pharmacological stimulation of eNOS expression and eNOS activity
  875. Area at Risk and Viability after Myocardial Ischemia and Reperfusion Can Be Determined by Contrast-Enhanced Cardiac Magnetic Resonance Imaging
  876. Activated thrombin activatable fibrinolysis inhibitor levels are associated with the risk of cardiovascular death in patients with coronary artery disease: the AtheroGenestudy
  877. Inactivation of Soluble Guanylate Cyclase by Stoichiometric S-Nitrosation
  878. Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction
  879. Regulation of erythrocyte survival by AMP-activated protein kinase
  880. Selenium supplementation improves antioxidant capacity in vitro and in vivo in patients with coronary artery disease
  881. Herzfrequenzreduktion bei der stabilen Angina pectoris und Ergebnisse zu Ivabradin
  882. Doubt about an essential role for constitutive nitric oxide synthase in nitroglycerin-mediated vasodilation
  883. PLTP activity is a risk factor for subsequent cardiovascular events in CAD patients under statin therapy: the AtheroGeneStudy
  884. B-type natriuretic peptide as a marker for sepsis-induced myocardial depression in intensive care patients*
  885. NOX5, a New “Radical” Player in Human Atherosclerosis?⁎⁎Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.
  886. Endotheliale Dysfunktion: Pathophysiologie, Diagnostik und prognostische Bedeutung
  887. Catheter ablation of an incessant ventricular tachycardia originating from the left aortic sinus cusp in an adolescent with subacute myocarditis
  888. Age-related atrial fibrosis
  889. Geschlechtsspezifische negative inotrope Wirkung von Übergewicht?
  890. Neue Erkenntnisse bei der Nitratwirkung, Nitratbioaktivierung und Toleranzentwicklung
  891. Intensive Lipid Lowering with Simvastatin and Ezetimibe in Aortic Stenosis
  892. Suppression of the JNK Pathway by Induction of a Metabolic Stress Response Prevents Vascular Injury and Dysfunction
  893. Suppression of the JNK Pathway by Induction of a Metabolic Stress Response Prevents Vascular Injury and Dysfunction
  894. Kriterien der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung für „Chest-Pain-Units“
  895. AT1-receptor blockade by telmisartan upregulates GTP-cyclohydrolase I and protects eNOS in diabetic rats
  896. Herzfrequenzreduktion bei der stabilen Angina pectoris und Ergebnisse zu Ivabradin
  897. Nitroglycerin Hits the Nerve
  898. Inflammatory pathways in patients with heart failure and preserved ejection fraction
  899. Anticoagulant and/or Antiplatelet Treatment in Patients with Atrial Fibrillation after Percutaneous Coronary Intervention
  900. Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial
  901. Different Calculations of Ankle-Brachial Index and Their Impact on Cardiovascular Risk Prediction
  902. First Evidence for a Crosstalk Between Mitochondrial and NADPH Oxidase-Derived Reactive Oxygen Species in Nitroglycerin-Triggered Vascular Dysfunction
  903. Manganese superoxide dismutase and aldehyde dehydrogenase deficiency increase mitochondrial oxidative stress and aggravate age-dependent vascular dysfunction
  904. Cyclooxygenase 2-Selective and Nonselective Nonsteroidal Anti-Inflammatory Drugs Induce Oxidative Stress by Up-Regulating Vascular NADPH Oxidases
  905. Impact of inflammatory markers on cardiovascular mortality in patients with metabolic syndrome
  906. Nitric Oxide, Tetrahydrobiopterin, Oxidative Stress, and Endothelial Dysfunction in Hypertension
  907. Sirolimus-Induced Vascular Dysfunction
  908. Facilitated PCI in Patients with ST-Elevation Myocardial Infarction
  909. Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus
  910. Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events
  911. Repeated Replication and a Prospective Meta-Analysis of the Association Between Chromosome 9p21.3 and Coronary Artery Disease
  912. The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study
  913. Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study
  914. ALDH-2 deficiency increases cardiovascular oxidative stress---Evidence for indirect antioxidative properties
  915. A single loading dose of clopidogrel causes dose-dependent improvement of endothelial dysfunction in patients with stable coronary artery disease: Results of a double-blind, randomized study
  916. Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction
  917. O44. Inhibition of CD98-associated amino acid transporters by dinitrosyl iron complexes
  918. Inflammation, atherosclerotic burden and cardiovascular prognosis
  919. Oxidative Inhibition of the Mitochondrial Aldehyde Dehydrogenase Promotes Nitroglycerin Tolerance in Human Blood Vessels
  920. Monocyte-derived dendritic cells of patients with coronary artery disease show an increased expression of costimulatory molecules CD40, CD80 and CD86 in vitro
  921. New insights into bioactivation of organic nitrates, nitrate tolerance and cross-tolerance
  922. Activation of polymorphonuclear neutrophils in patients with impaired left ventricular function
  923. AT1-receptor blockade with irbesartan improves peripheral but not coronary endothelial dysfunction in patients with stable coronary artery disease
  924. Nitroglycerine causes mitochondrial reactive oxygen species production: In vitro mechanistic insights
  925. Chest Pain Unit (CPU): erste Erfahrungen in Mainz
  926. Endothelin-1 in Humans Is Increased by Oxygen-Derived Radicals Ex Vivo and In Vivo
  927. Heme Oxygenase-1
  928. Interferon-γ Induces Chronic Active Myocarditis and Cardiomyopathy in Transgenic Mice
  929. Versorgung des akuten Koronarsyndromsin einer Chest Pain Unit - Eine sinnvolle Neuerung in Deutschland
  930. Resistin, acute coronary syndrome and prognosis results from the AtheroGene study
  931. Impact of Metabolic Syndrome on Atherosclerotic Burden and Cardiovascular Prognosis
  932. Increased superoxide production in nitrate tolerance is associated with NAD(P)H oxidase and aldehyde dehydrogenase 2 downregulation
  933. Differential effects of organic nitrates on endothelial progenitor cells are determined by oxidative stress
  934. Electron paramagnetic resonance (EPR) spin trapping of biological nitric oxide
  935. Targeting Heme-Oxidized Soluble Guanylate Cyclase
  936. Deficiency of Glutathione Peroxidase-1 Accelerates the Progression of Atherosclerosis in Apolipoprotein E-Deficient Mice
  937. Differential Effects of Organic Nitrates on Endothelial Progenitor Cells Are Determined by Oxidative Stress
  938. Glutathione Peroxidase-1 Activity, Atherosclerotic Burden, and Cardiovascular Prognosis
  939. Do We Still Need Organic Nitrates?⁎⁎Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.
  940. Number of nitrate groups determines reactivity and potency of organic nitrates: a proof of concept study in ALDH-2−/− mice
  941. Nitratbehandlung
  942. Role of Reduced Lipoic Acid in the Redox Regulation of Mitochondrial Aldehyde Dehydrogenase (ALDH-2) Activity
  943. Mechanisms underlying dysfunction of carotid arteries in genetically hyperlipidemic rabbits
  944. Pathogenese und Therapie des akuten Koronarsyndroms differenzieller Nutzen von GPIIb/IIIa-Rezeptorantagonisten bei Hochrisikopatienten
  945. Inhibition of Restenosis Development after Mechanical Injury: A New Field of Application for Malononitrilamides?
  946. Inhibition of xanthine oxidase improves myocardial contractility in patients with ischemic cardiomyopathy
  947. Nebivolol Inhibits Superoxide Formation by NADPH Oxidase and Endothelial Dysfunction in Angiotensin II–Treated Rats
  948. Normalization of endothelial dysfunction and vascular oxidative stress by chronic atorvastatin treatment in a rat model of streptozotocin-induced diabetes mellitus (type I)
  949. the role of mitochondrial aldehyde dehydrognase (ALDH-2) for bioactivation of organic nitrates: “Proof of concept” through investigations in ALDH-2 knockout mice
  950. Anti-oxidative effects in response to pentaerithrityl tetranitrate (PETN) treatment are mediated by heme oxygenase-1 and ferritin induction and prevent the development of nitrate tolerance and cross-tolerance in vivo
  951. Randomized, Double-Blind, Multicenter Study of the Endeavor Zotarolimus-Eluting Phosphorylcholine-Encapsulated Stent for Treatment of Native Coronary Artery Lesions
  952. Revascularisation of a Giant Coronary Artery Aneurysm in Suspected Incomplete Kawasaki-Disease
  953. NADPH Oxidase Accounts for Enhanced Superoxide Production and Impaired Endothelium-Dependent Smooth Muscle Relaxation in BKβ1 −/− Mice
  954. Comparative Impact of Multiple Biomarkers and N-Terminal Pro-Brain Natriuretic Peptide in the Context of Conventional Risk Factors for the Prediction of Recurrent Cardiovascular Events in the Heart Outcomes Prevention Evaluation (HOPE) Study
  955. Haplotypes of the Caspase-1 Gene, Plasma Caspase-1 Levels, and Cardiovascular Risk
  956. COX-2, Another Important Player in the Nitric Oxide–Endothelin Cross-Talk
  957. Reversal of Endothelial Nitric Oxide Synthase Uncoupling and Up-Regulation of Endothelial Nitric Oxide Synthase Expression Lowers Blood Pressure in Hypertensive Rats
  958. The selective estrogen receptor-β agonist biochanin A shows vasculoprotective effects without uterotrophic activity
  959. Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events
  960. Impact of C-reactive protein and fibrinogen on cardiovascular prognosis in patients with stable angina pectoris: the AtheroGene study
  961. Comparison of Fondaparinux and Enoxaparin in Acute Coronary Syndromes
  962. Endothelial Nitric Oxide Synthase in Vascular Disease
  963. Dinitrosyl-iron triggers apoptosis in Jurkat cells despite overexpression of Bcl-2
  964. B-Type Natriuretic Peptide and the Risk of Cardiovascular Events and Death in Patients With Stable Angina
  965. Potent low dose platelet inhibitory effects of clopidogrel and aspirin on coronary thrombus formation in an animal model of acute unstable angina
  966. Shunting of the Microcirculation After Mesenteric Ischemia and Reperfusion Is a Function of Ischemia Time and Increases Mortality
  967. Th-W51:7 Non-steroidal anti-inflammatory drugs up-regulate NADPH oxidase expression in spontaneously hypertensive rats
  968. Anti-Inflammatory Treatment with Standardized Human Serum Protein Solution Reduces Local and Systemic Inflammatory Response after Hemorrhagic Shock
  969. Hydralazine is a powerful inhibitor of peroxynitrite formation as a possible explanation for its beneficial effects on prognosis in patients with congestive heart failure
  970. Mechanisms of Increased Vascular Superoxide Production in an Experimental Model of Idiopathic Dilated Cardiomyopathy
  971. Oxypurinol improves coronary and peripheral endothelial function in patients with coronary artery disease
  972. The Oxidative Stress Concept of Nitrate Tolerance and the Antioxidant Properties of Hydralazine
  973. Explaining the Phenomenon of Nitrate Tolerance
  974. Asymmetric Dimethylarginine and the Risk of Cardiovascular Events and Death in Patients With Coronary Artery Disease
  975. Medikamentöse Therapie beim Patienten mit stabiler Angina pectoris
  976. Medikamentöse Therapie beim Patienten mit stabiler Angina pectoris (Antwortbogen)
  977. Medikamentöse Therapie beim Patienten mit stabiler Angina pectoris (Fragebogen)
  978. Differential effects of diabetes on the expression of the gp91phox homologues nox1 and nox4
  979. Vascular Consequences of Endothelial Nitric Oxide Synthase Uncoupling for the Activity and Expression of the Soluble Guanylyl Cyclase and the cGMP-Dependent Protein Kinase
  980. Nω-hydroxy-l-arginine homologues and hydroxylamine as nitric oxide-dependent vasorelaxant agents
  981. Glutathione Peroxidase-1 and Homocysteine for Cardiovascular Risk Prediction
  982. Preoperative Cardiovascular Evaluation Before Non-Cardial Surgery
  983. Should Treatment of Sepsis Include Statins?
  984. Physical Inactivity Increases Oxidative Stress, Endothelial Dysfunction, and Atherosclerosis
  985. Effect of tirofiban on percutaneous coronary intervention-induced endothelial dysfunction in patients with stable coronary artery disease
  986. Ist eine Therapie mit organischen Nitraten heute noch sinnvoll?
  987. Myeloperoxidase mediates neutrophil activation by association with CD11b/CD18 integrins
  988. Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: results from the AtheroGene study
  989. Myeloperoxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusion
  990. Surgical revision of an uncommonly dislocated self-expanding Amplatzer septal occluder device
  991. Emergency localization of radioactive seeds lost during intracoronary brachytherapy
  992. Endothelium- and nitric oxide-dependent vasorelaxing activities of gamma-butyrobetaine esters: possible link to the antiischemic activities of mildronate
  993. Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA
  994. Clinical aspects of reactive oxygen and nitrogen species
  995. Detection of Superoxide and Peroxynitrite in Model Systems and Mitochondria by the Luminol Analogue L-012
  996. 880-4 Intracoronary brachytherapy protects bifurcation lesions
  997. Central role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-tolerance
  998. Central role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-tolerance
  999. Chronic Arterial Responses to Polymer-Controlled Paclitaxel-Eluting Stents
  1000. Measurement of NAD(P)H oxidase-derived superoxide with the luminol analogue L-012

Showing 1,000 Stories.